cancer	inflammation	therapy	blood	complications	stimulation	conditions	experience	techniques	methods	proteins	illness	agents	functions	respiratory failure	bisphosphonates	inflammatory mediators	processes	modalities	therapies	malignancies	coagulation	approaches	disease	states	diseases	pathways	risk factors	vasculitis	abuse	neurological disorders	complication	conditions	environmental factors	hemostasis	aneurysm	fluids	multiple factors	mechanisms	soft tissues	systemic effects	atherothrombosis	body fluids	Comorbidities	inflammatory factors	cancers	biological processes	bone-targeted agents	fluid overload	non-specific symptoms	Other variables	osteoclast function	systemic factors	approaches	biological fluids	painful conditions	severe diseases	secondary effects	Other risk factors	Bone-targeted agents	antiresorptive agents	co-morbid conditions	objective signs	physiological responses	emotional factors	epidemiologic risk factors	side effects	smoking-related diseases	biofluids	life style factors	serious diseases	Post-operative complications	anti-resorptive agents	obesity-related diseases	bone resorption inhibitors	cellular responses	degenerative diseases	potent bone-targeted agents	serious disorders	Negative emotional states	adverse health effects	non-cardiovascular co-morbidities	pathologies	afflictions	anti-resorptive drugs	blood inflammatory markers	certain disease	concomitant illnesses	diagnostic specimens	disease areas	foreign materials	inflammatory cytokines	injectable biological fluids	irreversible events	irreversible results	medication	non-atherosclerotic etiology	osteoclast-targeting agents	pacemaker function	relevant processes	significant co morbidity	surrogate tissue	systemic bone-targeted agents	AO-related areas	Traditional drugs	adequate means	aortic arch diseases	biological state	comobidities	energy intake disease conditions	influence processes	intracranial vascular diseases	major diseases	major medical illnesses	many consequences	multiple significant adverse reactions	non-smokers.18 Other lifestyle factors	normal physiologic processes	others diseases	pathologic tissue destruction	proper cell lineages	respiratory system events	skeletal muscle injuries	“ anti-resorptive ” agents
treatment	cases	disease	risk	cancer	inflammation	symptoms	breast cancer	function	infection	heart failure	pain	therapy	asthma	factors	patient	risk factors	blood	complications	cardiovascular disease	tumors	effects	stimulation	conditions	lung cancer	progression	parameters	factor	stress	experience	heart	outcomes	events	lung	variables	techniques	drugs	areas	diseases	tissues	cancers	others	findings	comorbidities	lymphoma	methods	molecules	proteins	infections	disorders	bone resorption	illness	proinflammatory cytokines	cardiovascular events	sites	agents	endothelial dysfunction	functions	syncope	risks	side effects	adverse events	respiratory failure	bisphosphonates	medications	growth factors	problems	inflammatory mediators	cardiovascular diseases	cardiovascular risk factors	headache disorders	lung disease	metabolic syndrome	skeletal muscle	surgeons	factors	systemic inflammation	chronic inflammation	consequences	childhood	clinical features	processes	modalities	Factors	therapies	metabolic syndrome	causes	autoimmune diseases	target genes	malignancies	Mediators	agonists	coagulation	inflammatory diseases	adult patients	approaches	disease	states	psychiatric disorders	diseases	organs	chronic diseases	pathways	Risk factors	emotions	habits	hormones	risk factors	clinical parameters	patient characteristics	vasculitis	abuse	neurological disorders	complication	complaints	conditions	environmental factors	respiratory diseases	comorbid conditions	chronic lung disease	overload	myocardial injury	hemodynamic instability	cancers	hemostasis	consequences	several factors	vascular risk factors	inflammatory conditions	pathological conditions	co-morbidities	organs	behaviors	adulthood	risk factor	autoimmune disease	fluids	serious complications	many factors	tobacco smoke	pulmonary diseases	traditional risk factors	cause	neurodegenerative diseases	surgical interventions	symptoms	parameters	allergic diseases	substances	chronic conditions	multiple factors	important factors	chronic inflammatory diseases	clinical conditions	lung diseases	peripheral neuropathy	outcome measures	respiratory complications	mechanisms	vascular diseases	clinical factors	neurological symptoms	protein	chemotherapeutic agents	expressions	somatic symptoms	disease states	human diseases	mental disorders	neuropsychiatric disorders	soft tissues	mood disorders	subclinical atherosclerosis	Disorders	etiologies	metabolic diseases	health outcomes	medical conditions	mental illness	severe outcomes	important risk factors	systemic effects	lung transplant	severe complications	volume overload	atherothrombosis	systemic diseases	body fluids	autoimmune disorders	insults	characteristics	treatments	Comorbidities	inflammatory factors	comorbidities	immobility	cancers	hypercoagulability	complications	demographic factors	structural heart disease	different diseases	respiratory problems	multiple comorbidities	biological processes	bone diseases	mechanisms	malignancy	cancer types	cardiac risk factors	etiologies	various cancers	affective disorders	host factors	constitutional symptoms	microvascular disease	cardiovascular disorders	chronic inflammatory conditions	comorbidity	bone-targeted agents	airway diseases	potential complications	cardiac conditions	fluid overload	several diseases	pathologic conditions	inotropes	non-specific symptoms	Other variables	chronic diseases	lifestyle habits	neurological conditions	risk groups	neuropsychiatric symptoms	neurotransmitters	osteoclast function	psychological problems	systemic factors	allergic disorders	barotrauma	major adverse events	rare diseases	immune dysregulation	psychological factors	nonspecific symptoms	approaches	ischemic conditions	many diseases	tumours	various diseases	agents	biological fluids	cardiovascular symptoms	tumors	another disorder	multiple risk factors	peripheral tissues	additional risk factors	invasive mechanical ventilation	metabolic dysfunction	novel approaches	precipitants	Environmental factors	tissues	carcinogens	painful conditions	regulatory proteins	silicone	additional factors	causative factors	different tumors	possible confounders	left heart disease	severe diseases	autonomic regulation	complex disease	secondary effects	threats	underlying conditions	various malignancies	Other risk factors	illnesses	significant comorbidities	atherosclerotic risk factors	clinical outcomes	obstructive lung diseases	certain situations	long-term side effects	specific diseases	Bone-targeted agents	different stimuli	intracranial lesions	common comorbidities	exogenous sources	sensory symptoms	specific domains	antiresorptive agents	co-morbid conditions	metabolic bone diseases	objective signs	obstructive lung disease	physiological responses	related conditions	secreted proteins	underlying diseases	vascular risk factors	All factors	cardiac manifestations	chronic inflammatory condition	chronic medical conditions	clinical details	comorbid condition	increased sympathetic activity	multifactorial diseases	negative feelings	peripheral neuropathies	proinflammatory conditions	psychiatric diseases	various complications	acute respiratory events	certain risk factors	emotional factors	epidemiologic risk factors	neuropsychiatric manifestations	non-communicable diseases	patient-centered outcomes	side effects	significant symptoms	smoking-related diseases	All variables	Other complications	Psychosocial factors	anastomotic leak	antecedent events	biofluids	chronic health conditions	co-morbidities	life style factors	noncommunicable diseases	serious diseases	various symptoms	vascular conditions	Post-operative complications	ailments	anti-resorptive agents	categorical predictors	chronic lung disease	different variables	excessive bone resorption	medical comorbidity	obesity-related diseases	significant complications	Clinical conditions	Outcomes	bone resorption inhibitors	cellular responses	chronic comorbidities	chronic inflammatory lung diseases	high-risk subgroups	lifestyle-related diseases	neuropsychiatric factors	neuropsychiatric features	acute conditions	benign entities	chronic respiratory diseases	co-morbid diseases	degenerative diseases	hormone-dependent cancers	immunocompromised hosts	insult	interventricular delay	lifestyle exposures	many tumours	possible problems	post-operative complications	potent bone-targeted agents	pulmonary disorders	secondary repolarization abnormalities	serious disorders	solid tumour	substantial risk	systemic circulation	tumor types	Negative emotional states	adverse health effects	chronic respiratory illnesses	common source	disease-associated factors	experimental interventions	external signals	frequent adverse events	intravenous contrast	non-cardiovascular co-morbidities	non-specific constitutional symptoms	pathologies	systemic pathologies	COPD-related diseases	afflictions	anti-resorptive drugs	biologic substances	blood inflammatory markers	certain cancer types	certain disease	chronic medical conditions	co-existing diseases	concomitant illnesses	constitutional symptoms	diagnostic specimens	disease areas	diverse disorders	experiential phenomena	explanatory variables	foreign materials	gastric complications	heterogeneous entities	important symptom	incident cardiovascular disease events	inflammatory cytokines	inflammatory respiratory diseases	injectable biological fluids	irreversible events	irreversible results	lung conditions	medical complications	medication	non-atherosclerotic etiology	osteoclast-targeting agents	pacemaker function	pathological settings	perioperative side effects	postprocedural complications	prevalent pulmonary diseases	pulmonary illness	relevant processes	self-perceived aspects	several cardiovascular conditions	significant co morbidity	special diseases	surrogate tissue	systemic bone-targeted agents	vasopressin production	AO-related areas	Alloplastic materials	Complex diseases	IgE-dependent diseases	Mechanical parameters	No major acute complications	Pre-operative risk factors	Psychiatric sequelae	Psychological comorbidities	Short-term risks	Some perceived barriers	Th2-related disease	The standard risk factors	Traditional drugs	acute event	acute thromboembolic events	additional cardiovascular co-morbidities	address lifestyle factors	adequate means	administrative characteristics	age-related comorbidities	age-related problems	airway inflammations	arrhythmic risk factors	asymptomatic chronic diseases	biochemistry factors	biological state	bone osteolysis	bone-related disorders	bronchial etiologies	cardiovascular diseases	cardiovascular risk comorbidities	certain common symptoms	chronic airway inflammatory diseases	chronic autoimmune diseases	chronic lung conditions	chronic medical condition	chronic obstructive lung diseases	chronic pulmonary disorders	classic cardiovascular risk factors	co-existing systemic disease	common comorbid conditions	community-acquired infections	comobidities	comparable samples	complex disorders	concomitant inflammatory diseases	current additional allergic symptoms	current medical conditions	different carcinoma localizations	different clinical setting	different environmental exposures	different target organs	diffuse ischemia	driven diseases	energy intake disease conditions	event risks	exhibits several COPD-associated co-morbidities	experience side effects	frequent co-morbidities,43	gastrointestinal complications	generalized vascular pathology	high comorbidity	high device-related complications	high oxidative capacity	high-risk features	higher-risk features	human airways diseases	ictal phenomena	important co-morbidites	important comorbidities	inappropriate reasons	inflammatory lung diseases	influence processes	insulin-sensitive organs	irritative sensory features	long term support complications	long-term pulmonary impairments	longer-term complications	low-incidence complications	major atherosclerotic macrovascular events	major diseases	major inflammatory diseases	major medical illnesses	many connective tissue diseases	many consequences	many immune-related diseases	mental states	microtubule-targeted drugs	migraine trigger	multi-factorial disorder	multiple significant adverse reactions	negative factors	neurotic symptoms	non respiratory factors	non-smokers.18 Other lifestyle factors	nonemotional characteristics	normal disease tissues	normal physiologic processes	numerous neuropsychiatric disorders	organ toxicities	osteolytic bone conditions	others diseases	palliative care symptoms	pathologic tissue destruction	permanent serious disease	physical barriers	possessed risk factors	potent biochemical mediators	pre-existing chronic diseases	primary sites	prior non-malignant lung disease	progenitor states	proper cell lineages	psychiatric distress	reflect distress	relevant entity	respiratory system events	score,43 comorbidities	secondary dyslipidemias	significant behavioral health concerns	significant inflammatory component	similar circumstances	skeletal muscle injuries	smoking hazards	soft tissue involvement	special medications	specific physical stimuli	strong vascular risk factors	systematic status	tissue symptoms	tongue symptoms	unrecognised.1 Characteristics	unwanted consequences	usual cardiovascular risk factors	various cancer entities	various health-related issues	various respiratory health problems	well-known adolescent public health problems	well-known pathologies	young adult mice	’ prenatal history	“ anti-resorptive ” agents	“ off-label ” indications
therapy	blood	stimulation	methods	agents	functions	modalities	therapies	approaches	disease	states	pathways	vasculitis	abuse	neurological disorders	complication	environmental factors	fluids	multiple factors	zoledronic acid	mechanisms	soft tissues	body fluids	cancers	bone-targeted agents	osteoclast function	approaches	biological fluids	Other risk factors	Bone-targeted agents	antiresorptive agents	epidemiologic risk factors	biofluids	life style factors	anti-resorptive agents	potent bone-targeted agents	diagnostic specimens	foreign materials	injectable biological fluids	non-atherosclerotic etiology	pacemaker function	surrogate tissue	biological state	multiple significant adverse reactions	non-smokers.18 Other lifestyle factors	proper cell lineages	“ anti-resorptive ” agents
treatment	disease	cancer	inflammation	symptoms	breast cancer	function	infection	pain	therapy	asthma	factors	patient	risk factors	blood	complications	cardiovascular disease	tumors	stimulation	conditions	lung cancer	progression	parameters	stress	experience	outcomes	lung	variables	techniques	areas	diseases	comorbidities	lymphoma	methods	proteins	infections	bone resorption	illness	sites	agents	functions	syncope	risks	side effects	adverse events	respiratory failure	bisphosphonates	medications	inflammatory mediators	cardiovascular diseases	cardiovascular risk factors	headache disorders	lung disease	metabolic syndrome	skeletal muscle	systemic inflammation	chronic inflammation	childhood	clinical features	processes	modalities	Factors	therapies	metabolic syndrome	causes	autoimmune diseases	malignancies	coagulation	inflammatory diseases	adult patients	approaches	disease	states	diseases	organs	chronic diseases	pathways	Risk factors	habits	risk factors	clinical parameters	patient characteristics	vasculitis	abuse	neurological disorders	complication	complaints	conditions	environmental factors	respiratory diseases	comorbid conditions	chronic lung disease	overload	hemostasis	consequences	several factors	vascular risk factors	pathological conditions	co-morbidities	organs	autoimmune disease	fluids	serious complications	many factors	tobacco smoke	pulmonary diseases	cause	neurodegenerative diseases	surgical interventions	symptoms	parameters	allergic diseases	chronic conditions	multiple factors	chronic inflammatory diseases	clinical conditions	lung diseases	peripheral neuropathy	respiratory complications	mechanisms	vascular diseases	clinical factors	protein	expressions	somatic symptoms	disease states	human diseases	soft tissues	Disorders	etiologies	metabolic diseases	severe outcomes	systemic effects	lung transplant	atherothrombosis	systemic diseases	body fluids	autoimmune disorders	insults	characteristics	treatments	Comorbidities	inflammatory factors	comorbidities	cancers	hypercoagulability	complications	demographic factors	respiratory problems	multiple comorbidities	biological processes	bone diseases	malignancy	cardiac risk factors	etiologies	various cancers	host factors	constitutional symptoms	chronic inflammatory conditions	comorbidity	empyema	bone-targeted agents	airway diseases	potential complications	fluid overload	pathologic conditions	non-specific symptoms	Other variables	chronic diseases	neurological conditions	osteoclast function	systemic factors	allergic disorders	rare diseases	immune dysregulation	nonspecific symptoms	approaches	ischemic conditions	many diseases	tumours	various diseases	biological fluids	cardiovascular symptoms	tumors	another disorder	peripheral tissues	metabolic dysfunction	novel approaches	precipitants	Environmental factors	tissues	painful conditions	different tumors	possible confounders	severe diseases	autonomic regulation	complex disease	secondary effects	threats	underlying conditions	various malignancies	Other risk factors	illnesses	significant comorbidities	atherosclerotic risk factors	clinical outcomes	obstructive lung diseases	long-term side effects	specific diseases	Bone-targeted agents	common comorbidities	sensory symptoms	antiresorptive agents	co-morbid conditions	metabolic bone diseases	objective signs	obstructive lung disease	physiological responses	underlying diseases	vascular risk factors	All factors	chronic inflammatory condition	chronic medical conditions	clinical details	comorbid condition	multifactorial diseases	peripheral neuropathies	various complications	acute respiratory events	certain risk factors	emotional factors	epidemiologic risk factors	neuropsychiatric manifestations	patient-centered outcomes	side effects	significant symptoms	smoking-related diseases	All variables	Other complications	antecedent events	biofluids	chronic health conditions	life style factors	noncommunicable diseases	serious diseases	Post-operative complications	ailments	anti-resorptive agents	categorical predictors	chronic lung disease	different variables	excessive bone resorption	medical comorbidity	obesity-related diseases	significant complications	Clinical conditions	bone resorption inhibitors	cellular responses	chronic inflammatory lung diseases	benign entities	chronic respiratory diseases	co-morbid diseases	degenerative diseases	hormone-dependent cancers	insult	interventricular delay	possible problems	post-operative complications	potent bone-targeted agents	pulmonary disorders	serious disorders	solid tumour	substantial risk	Negative emotional states	adverse health effects	chronic respiratory illnesses	common source	disease-associated factors	experimental interventions	external signals	frequent adverse events	intravenous contrast	non-cardiovascular co-morbidities	non-specific constitutional symptoms	pathologies	systemic pathologies	COPD-related diseases	afflictions	anti-resorptive drugs	blood inflammatory markers	certain cancer types	certain disease	chronic medical conditions	co-existing diseases	concomitant illnesses	constitutional symptoms	diagnostic specimens	disease areas	diverse disorders	experiential phenomena	explanatory variables	foreign materials	gastric complications	heterogeneous entities	important symptom	inflammatory cytokines	inflammatory respiratory diseases	injectable biological fluids	irreversible events	irreversible results	lung conditions	medical complications	medication	non-atherosclerotic etiology	osteoclast-targeting agents	pacemaker function	pathological settings	perioperative side effects	postprocedural complications	prevalent pulmonary diseases	pulmonary illness	relevant processes	self-perceived aspects	several cardiovascular conditions	significant co morbidity	special diseases	surrogate tissue	systemic bone-targeted agents	vasopressin production	AO-related areas	Complex diseases	IgE-dependent diseases	Mechanical parameters	Short-term risks	Some perceived barriers	Th2-related disease	The standard risk factors	Traditional drugs	acute event	address lifestyle factors	adequate means	administrative characteristics	age-related comorbidities	age-related problems	airway inflammations	arrhythmic risk factors	biological state	bone osteolysis	bone-related disorders	bronchial etiologies	certain common symptoms	chronic airway inflammatory diseases	chronic autoimmune diseases	chronic lung conditions	chronic obstructive lung diseases	chronic pulmonary disorders	co-existing systemic disease	common comorbid conditions	community-acquired infections	comobidities	complex disorders	concomitant inflammatory diseases	current additional allergic symptoms	current medical conditions	different carcinoma localizations	different environmental exposures	different target organs	driven diseases	energy intake disease conditions	exhibits several COPD-associated co-morbidities	experience side effects	gastrointestinal complications	high comorbidity	high device-related complications	high-risk features	human airways diseases	important comorbidities	inflammatory lung diseases	influence processes	insulin-sensitive organs	irritative sensory features	long term support complications	long-term pulmonary impairments	longer-term complications	major diseases	major inflammatory diseases	major medical illnesses	many connective tissue diseases	many consequences	many immune-related diseases	mental states	migraine trigger	multi-factorial disorder	multiple significant adverse reactions	negative factors	non-smokers.18 Other lifestyle factors	nonemotional characteristics	normal physiologic processes	organ toxicities	osteolytic bone conditions	others diseases	palliative care symptoms	pathologic tissue destruction	physical barriers	possessed risk factors	pre-existing chronic diseases	primary sites	prior non-malignant lung disease	progenitor states	proper cell lineages	relevant entity	respiratory system events	skeletal muscle injuries	smoking hazards	soft tissue involvement	specific physical stimuli	systematic status	tissue symptoms	tongue symptoms	unrecognised.1 Characteristics	various health-related issues	various respiratory health problems	well-known adolescent public health problems	well-known pathologies	young adult mice	’ prenatal history	“ anti-resorptive ” agents
treatment	disease	cancer	inflammation	symptoms	breast cancer	function	infection	pain	therapy	asthma	factors	patient	risk factors	blood	complications	cardiovascular disease	tumors	stimulation	conditions	lung cancer	progression	parameters	stress	experience	outcomes	lung	variables	techniques	areas	diseases	comorbidities	lymphoma	methods	proteins	infections	bone resorption	illness	sites	agents	functions	syncope	risks	side effects	adverse events	respiratory failure	bisphosphonates	medications	cystic fibrosis	inflammatory mediators	headache disorders	lung disease	metabolic syndrome	skeletal muscle	systemic inflammation	chronic inflammation	childhood	clinical features	processes	modalities	Factors	therapies	metabolic syndrome	causes	autoimmune diseases	malignancies	coagulation	inflammatory diseases	adult patients	approaches	disease	states	diseases	organs	chronic diseases	pathways	Risk factors	habits	risk factors	clinical parameters	patient characteristics	vasculitis	abuse	neurological disorders	complication	complaints	conditions	environmental factors	respiratory diseases	comorbid conditions	chronic lung disease	overload	hemostasis	consequences	several factors	pathological conditions	organs	autoimmune disease	fluids	many factors	tobacco smoke	pulmonary diseases	cause	neurodegenerative diseases	surgical interventions	symptoms	parameters	allergic diseases	chronic conditions	multiple factors	chronic inflammatory diseases	clinical conditions	lung diseases	peripheral neuropathy	respiratory complications	mechanisms	clinical factors	protein	expressions	somatic symptoms	disease states	soft tissues	Disorders	metabolic diseases	systemic effects	lung transplant	atherothrombosis	body fluids	insults	characteristics	treatments	Comorbidities	inflammatory factors	comorbidities	cancers	hypercoagulability	complications	demographic factors	respiratory problems	biological processes	bone diseases	malignancy	etiologies	various cancers	host factors	constitutional symptoms	chronic inflammatory conditions	bone-targeted agents	airway diseases	potential complications	fluid overload	pathologic conditions	non-specific symptoms	Other variables	chronic diseases	neurological conditions	osteoclast function	systemic factors	allergic disorders	rare diseases	immune dysregulation	nonspecific symptoms	approaches	ischemic conditions	many diseases	tumours	various diseases	biological fluids	cardiovascular symptoms	tumors	peripheral tissues	metabolic dysfunction	novel approaches	precipitants	Environmental factors	tissues	painful conditions	chronic hypoxia	different tumors	possible confounders	severe diseases	autonomic regulation	complex disease	secondary effects	threats	underlying conditions	various malignancies	Other risk factors	illnesses	significant comorbidities	clinical outcomes	obstructive lung diseases	long-term side effects	specific diseases	Bone-targeted agents	common comorbidities	sensory symptoms	antiresorptive agents	co-morbid conditions	metabolic bone diseases	objective signs	obstructive lung disease	physiological responses	underlying diseases	vascular risk factors	All factors	chronic disease	chronic inflammatory condition	clinical details	comorbid condition	multifactorial diseases	peripheral neuropathies	various complications	emotional factors	epidemiologic risk factors	neuropsychiatric manifestations	patient-centered outcomes	side effects	significant symptoms	smoking-related diseases	All variables	Other complications	antecedent events	biofluids	chronic health conditions	life style factors	noncommunicable diseases	serious diseases	Post-operative complications	anti-resorptive agents	categorical predictors	chronic lung disease	different variables	excessive bone resorption	medical comorbidity	obesity-related diseases	significant complications	Clinical conditions	bone resorption inhibitors	cellular responses	chronic inflammatory lung diseases	benign entities	chronic respiratory diseases	degenerative diseases	hormone-dependent cancers	inflammatory lung disease	insult	interventricular delay	possible problems	post-operative complications	potent bone-targeted agents	pulmonary disorders	serious disorders	solid tumour	substantial risk	Negative emotional states	adverse health effects	chronic respiratory illnesses	common source	disease-associated factors	experimental interventions	external signals	frequent adverse events	inflammatory lung diseases	intravenous contrast	non-cardiovascular co-morbidities	non-specific constitutional symptoms	pathologies	systemic pathologies	afflictions	anti-resorptive drugs	blood inflammatory markers	certain cancer types	certain disease	chronic medical conditions	co-existing diseases	concomitant illnesses	constitutional symptoms	diagnostic specimens	disease areas	diverse disorders	experiential phenomena	explanatory variables	foreign materials	gastric complications	heterogeneous entities	important symptom	inflammatory cytokines	inflammatory respiratory diseases	injectable biological fluids	irreversible events	irreversible results	lung conditions	medical complications	medication	non-atherosclerotic etiology	osteoclast-targeting agents	pacemaker function	pathological settings	perioperative side effects	postprocedural complications	prevalent pulmonary diseases	pulmonary illness	relevant processes	self-perceived aspects	several cardiovascular conditions	significant co morbidity	special diseases	surrogate tissue	systemic bone-targeted agents	vasopressin production	AO-related areas	Complex diseases	IgE-dependent diseases	Mechanical parameters	Short-term risks	Some perceived barriers	Th2-related disease	The standard risk factors	Traditional drugs	acute event	address lifestyle factors	adequate means	administrative characteristics	age-related problems	airway inflammations	arrhythmic risk factors	biological state	bone osteolysis	bone-related disorders	bronchial etiologies	certain common symptoms	chronic airway inflammatory diseases	chronic autoimmune diseases	chronic lung conditions	chronic obstructive lung diseases	chronic pulmonary disorders	common comorbid conditions	comobidities	complex disorders	concomitant inflammatory diseases	current additional allergic symptoms	different carcinoma localizations	different target organs	driven diseases	energy intake disease conditions	experience side effects	gastrointestinal complications	high comorbidity	high device-related complications	human airways diseases	important comorbidities	inflammatory lung diseases	influence processes	insulin-sensitive organs	irritative sensory features	long term support complications	long-term pulmonary impairments	major diseases	major inflammatory diseases	major medical illnesses	many consequences	many immune-related diseases	mental states	migraine trigger	multi-factorial disorder	multiple significant adverse reactions	negative factors	non-smokers.18 Other lifestyle factors	nonemotional characteristics	normal physiologic processes	organ toxicities	osteolytic bone conditions	others diseases	palliative care symptoms	pathologic tissue destruction	physical barriers	possessed risk factors	primary sites	prior non-malignant lung disease	progenitor states	proper cell lineages	relevant entity	respiratory system events	skeletal muscle injuries	smoking hazards	soft tissue involvement	specific physical stimuli	systematic status	tissue symptoms	tongue symptoms	unrecognised.1 Characteristics	various health-related issues	various respiratory health problems	well-known adolescent public health problems	well-known pathologies	young adult mice	’ prenatal history	“ anti-resorptive ” agents
treatment	cases	disease	risk	cancer	inflammation	symptoms	breast cancer	function	infection	heart failure	pain	therapy	asthma	factors	patient	risk factors	blood	complications	cardiovascular disease	tumors	stimulation	conditions	lung cancer	progression	parameters	factor	stress	experience	heart	outcomes	events	lung	variables	techniques	drugs	areas	diseases	findings	comorbidities	lymphoma	methods	proteins	infections	bone resorption	illness	cardiovascular events	sites	agents	endothelial dysfunction	functions	syncope	risks	side effects	adverse events	respiratory failure	bisphosphonates	medications	inflammatory mediators	cardiovascular diseases	cardiovascular risk factors	headache disorders	lung disease	metabolic syndrome	skeletal muscle	surgeons	factors	systemic inflammation	chronic inflammation	consequences	childhood	clinical features	processes	modalities	Factors	therapies	metabolic syndrome	causes	autoimmune diseases	malignancies	coagulation	inflammatory diseases	adult patients	approaches	disease	states	diseases	organs	chronic diseases	pathways	Risk factors	habits	risk factors	clinical parameters	patient characteristics	vasculitis	abuse	neurological disorders	complication	complaints	conditions	environmental factors	respiratory diseases	comorbid conditions	chronic lung disease	overload	myocardial injury	hemodynamic instability	hemostasis	consequences	several factors	vascular risk factors	pathological conditions	co-morbidities	organs	adulthood	risk factor	autoimmune disease	fluids	serious complications	many factors	tobacco smoke	pulmonary diseases	traditional risk factors	cause	neurodegenerative diseases	surgical interventions	symptoms	parameters	allergic diseases	chronic conditions	multiple factors	chronic inflammatory diseases	clinical conditions	lung diseases	peripheral neuropathy	outcome measures	respiratory complications	mechanisms	vascular diseases	clinical factors	protein	chemotherapeutic agents	expressions	somatic symptoms	disease states	human diseases	soft tissues	subclinical atherosclerosis	Disorders	etiologies	metabolic diseases	health outcomes	medical conditions	severe outcomes	important risk factors	systemic effects	lung transplant	severe complications	volume overload	atherothrombosis	systemic diseases	body fluids	autoimmune disorders	insults	characteristics	treatments	Comorbidities	inflammatory factors	comorbidities	immobility	cancers	hypercoagulability	complications	demographic factors	structural heart disease	different diseases	respiratory problems	multiple comorbidities	biological processes	bone diseases	mechanisms	malignancy	cardiac risk factors	etiologies	various cancers	host factors	constitutional symptoms	microvascular disease	cardiovascular disorders	chronic inflammatory conditions	comorbidity	bone-targeted agents	airway diseases	potential complications	cardiac conditions	fluid overload	several diseases	pathologic conditions	inotropes	non-specific symptoms	Other variables	chronic diseases	lifestyle habits	neurological conditions	risk groups	neurotransmitters	osteoclast function	systemic factors	allergic disorders	barotrauma	major adverse events	rare diseases	immune dysregulation	nonspecific symptoms	approaches	ischemic conditions	many diseases	tumours	various diseases	agents	biological fluids	cardiovascular symptoms	tumors	another disorder	multiple risk factors	peripheral tissues	additional risk factors	invasive mechanical ventilation	metabolic dysfunction	novel approaches	precipitants	Environmental factors	tissues	carcinogens	painful conditions	additional factors	causative factors	different tumors	possible confounders	left heart disease	severe diseases	autonomic regulation	complex disease	secondary effects	threats	underlying conditions	various malignancies	Other risk factors	illnesses	significant comorbidities	atherosclerotic risk factors	clinical outcomes	obstructive lung diseases	certain situations	long-term side effects	specific diseases	Bone-targeted agents	common comorbidities	exogenous sources	osteitis	sensory symptoms	antiresorptive agents	co-morbid conditions	metabolic bone diseases	objective signs	obstructive lung disease	physiological responses	related conditions	underlying diseases	vascular risk factors	All factors	cardiac manifestations	chronic inflammatory condition	chronic medical conditions	clinical details	comorbid condition	increased sympathetic activity	multifactorial diseases	peripheral neuropathies	proinflammatory conditions	various complications	acute respiratory events	certain risk factors	emotional factors	epidemiologic risk factors	neuropsychiatric manifestations	non-communicable diseases	patient-centered outcomes	side effects	significant symptoms	smoking-related diseases	All variables	Other complications	antecedent events	biofluids	chronic health conditions	co-morbidities	life style factors	noncommunicable diseases	serious diseases	Post-operative complications	ailments	anti-resorptive agents	categorical predictors	chronic lung disease	different variables	excessive bone resorption	medical comorbidity	obesity-related diseases	significant complications	Clinical conditions	Outcomes	bone resorption inhibitors	cellular responses	chronic comorbidities	chronic inflammatory lung diseases	high-risk subgroups	lifestyle-related diseases	acute conditions	benign entities	chronic respiratory diseases	co-morbid diseases	degenerative diseases	hormone-dependent cancers	immunocompromised hosts	insult	interventricular delay	lifestyle exposures	possible problems	post-operative complications	potent bone-targeted agents	pulmonary disorders	secondary repolarization abnormalities	serious disorders	solid tumour	substantial risk	systemic circulation	Negative emotional states	adverse health effects	chronic respiratory illnesses	common source	disease-associated factors	experimental interventions	external signals	frequent adverse events	intravenous contrast	non-cardiovascular co-morbidities	non-specific constitutional symptoms	pathologies	systemic pathologies	COPD-related diseases	afflictions	anti-resorptive drugs	blood inflammatory markers	certain cancer types	certain disease	chronic medical conditions	co-existing diseases	concomitant illnesses	constitutional symptoms	diagnostic specimens	disease areas	diverse disorders	experiential phenomena	explanatory variables	foreign materials	gastric complications	heterogeneous entities	important symptom	incident cardiovascular disease events	inflammatory cytokines	inflammatory respiratory diseases	injectable biological fluids	irreversible events	irreversible results	lung conditions	medical complications	medication	non-atherosclerotic etiology	osteoclast-targeting agents	pacemaker function	pathological settings	perioperative side effects	postprocedural complications	prevalent pulmonary diseases	pulmonary illness	relevant processes	self-perceived aspects	several cardiovascular conditions	significant co morbidity	special diseases	surrogate tissue	systemic bone-targeted agents	vasopressin production	AO-related areas	Complex diseases	IgE-dependent diseases	Mechanical parameters	No major acute complications	Pre-operative risk factors	Short-term risks	Some perceived barriers	Th2-related disease	The standard risk factors	Traditional drugs	acute event	acute thromboembolic events	additional cardiovascular co-morbidities	address lifestyle factors	adequate means	administrative characteristics	age-related comorbidities	age-related problems	airway inflammations	arrhythmic risk factors	asymptomatic chronic diseases	biological state	bone osteolysis	bone-related disorders	bronchial etiologies	cardiovascular diseases	cardiovascular risk comorbidities	certain common symptoms	chronic airway inflammatory diseases	chronic autoimmune diseases	chronic lung conditions	chronic medical condition	chronic obstructive lung diseases	chronic pulmonary disorders	classic cardiovascular risk factors	co-existing systemic disease	common comorbid conditions	community-acquired infections	comobidities	comparable samples	complex disorders	concomitant inflammatory diseases	current additional allergic symptoms	current medical conditions	different carcinoma localizations	different clinical setting	different environmental exposures	different target organs	diffuse ischemia	driven diseases	energy intake disease conditions	event risks	exhibits several COPD-associated co-morbidities	experience side effects	frequent co-morbidities,43	gastrointestinal complications	generalized vascular pathology	high comorbidity	high device-related complications	high oxidative capacity	high-risk features	higher-risk features	human airways diseases	ictal phenomena	important co-morbidites	important comorbidities	inflammatory lung diseases	influence processes	insulin-sensitive organs	irritative sensory features	long term support complications	long-term pulmonary impairments	longer-term complications	major atherosclerotic macrovascular events	major diseases	major inflammatory diseases	major medical illnesses	many connective tissue diseases	many consequences	many immune-related diseases	mental states	microtubule-targeted drugs	migraine trigger	multi-factorial disorder	multiple significant adverse reactions	negative factors	non-smokers.18 Other lifestyle factors	nonemotional characteristics	normal physiologic processes	organ toxicities	osteolytic bone conditions	others diseases	palliative care symptoms	pathologic tissue destruction	permanent serious disease	physical barriers	possessed risk factors	pre-existing chronic diseases	primary sites	prior non-malignant lung disease	progenitor states	proper cell lineages	relevant entity	respiratory system events	score,43 comorbidities	secondary dyslipidemias	significant inflammatory component	similar circumstances	skeletal muscle injuries	smoking hazards	soft tissue involvement	specific physical stimuli	strong vascular risk factors	systematic status	tissue symptoms	tongue symptoms	unrecognised.1 Characteristics	usual cardiovascular risk factors	various health-related issues	various respiratory health problems	well-known adolescent public health problems	well-known pathologies	young adult mice	’ prenatal history	“ anti-resorptive ” agents
disease	cancer	inflammation	function	therapy	patient	risk factors	blood	complications	stimulation	conditions	progression	experience	outcomes	lung	techniques	comorbidities	methods	proteins	illness	sites	agents	functions	respiratory failure	bisphosphonates	inflammatory mediators	lung disease	metabolic syndrome	skeletal muscle	chronic inflammation	clinical features	processes	modalities	therapies	malignancies	coagulation	inflammatory diseases	approaches	disease	states	diseases	organs	pathways	risk factors	rhinitis	vasculitis	abuse	neurological disorders	complication	conditions	environmental factors	chronic lung disease	hemostasis	organs	fluids	tobacco smoke	pulmonary diseases	neurodegenerative diseases	parameters	allergic diseases	multiple factors	mechanisms	protein	disease states	soft tissues	Disorders	systemic effects	atherothrombosis	body fluids	Comorbidities	inflammatory factors	cancers	respiratory problems	biological processes	host factors	bone-targeted agents	airway diseases	fluid overload	non-specific symptoms	Other variables	osteoclast function	systemic factors	allergic disorders	approaches	tumours	biological fluids	peripheral tissues	tissues	painful conditions	different tumors	severe diseases	secondary effects	Other risk factors	long-term side effects	Bone-targeted agents	antiresorptive agents	co-morbid conditions	objective signs	physiological responses	underlying diseases	multifactorial diseases	emotional factors	epidemiologic risk factors	side effects	smoking-related diseases	biofluids	life style factors	serious diseases	Post-operative complications	anti-resorptive agents	chronic lung disease	different variables	obesity-related diseases	bone resorption inhibitors	cellular responses	chronic inflammatory lung diseases	chronic respiratory diseases	degenerative diseases	interventricular delay	potent bone-targeted agents	pulmonary disorders	serious disorders	Negative emotional states	adverse health effects	chronic respiratory illnesses	non-cardiovascular co-morbidities	pathologies	afflictions	anti-resorptive drugs	blood inflammatory markers	certain disease	concomitant illnesses	diagnostic specimens	disease areas	foreign materials	inflammatory cytokines	injectable biological fluids	irreversible events	irreversible results	medication	non-atherosclerotic etiology	osteoclast-targeting agents	pacemaker function	pulmonary illness	relevant processes	significant co morbidity	surrogate tissue	systemic bone-targeted agents	AO-related areas	Traditional drugs	adequate means	age-related problems	biological state	bronchial etiologies	chronic lung conditions	chronic obstructive lung diseases	comobidities	different target organs	energy intake disease conditions	inflammatory lung diseases	influence processes	insulin-sensitive organs	major diseases	major medical illnesses	many consequences	multi-factorial disorder	multiple significant adverse reactions	negative factors	non-smokers.18 Other lifestyle factors	normal physiologic processes	others diseases	pathologic tissue destruction	physical barriers	primary sites	proper cell lineages	respiratory system events	skeletal muscle injuries	smoking hazards	young adult mice	“ anti-resorptive ” agents
therapy	blood	stimulation	techniques	methods	agents	functions	bisphosphonates	magnetic resonance imaging	processes	modalities	therapies	coagulation	approaches	disease	states	pathways	vasculitis	abuse	neurological disorders	complication	environmental factors	hemostasis	fluids	multiple factors	mechanisms	soft tissues	body fluids	cancers	bone-targeted agents	osteoclast function	approaches	biological fluids	Other risk factors	Bone-targeted agents	antiresorptive agents	epidemiologic risk factors	biofluids	life style factors	anti-resorptive agents	bone resorption inhibitors	potent bone-targeted agents	anti-resorptive drugs	diagnostic specimens	foreign materials	injectable biological fluids	medication	non-atherosclerotic etiology	osteoclast-targeting agents	pacemaker function	surrogate tissue	systemic bone-targeted agents	Traditional drugs	adequate means	biological state	gold-standards	multiple significant adverse reactions	non-smokers.18 Other lifestyle factors	proper cell lineages	unnecessary auxiliary examinations	“ anti-resorptive ” agents
treatment	cases	disease	risk	cancer	migraine	inflammation	headache	symptoms	breast cancer	function	infection	heart failure	pain	therapy	asthma	factors	patient	risk factors	blood	complications	cardiovascular disease	tumors	stimulation	conditions	lung cancer	progression	parameters	factor	stress	experience	heart	outcomes	events	lung	variables	techniques	drugs	areas	diseases	headaches	tissues	cancers	others	findings	comorbidities	lymphoma	methods	molecules	proteins	infections	disorders	bone resorption	illness	proinflammatory cytokines	cardiovascular events	sites	agents	endothelial dysfunction	functions	syncope	risks	side effects	adverse events	respiratory failure	bisphosphonates	medications	growth factors	problems	inflammatory mediators	cardiovascular diseases	cardiovascular risk factors	headache disorders	lung disease	metabolic syndrome	skeletal muscle	surgeons	factors	systemic inflammation	chronic inflammation	consequences	childhood	clinical features	processes	modalities	Factors	therapies	metabolic syndrome	causes	autoimmune diseases	primary headaches	target genes	malignancies	Mediators	agonists	coagulation	inflammatory diseases	adult patients	approaches	disease	states	primary headache	diseases	organs	chronic diseases	pathways	intracranial pressure	Risk factors	habits	hormones	risk factors	clinical parameters	patient characteristics	vasculitis	abuse	neurological disorders	complication	complaints	conditions	environmental factors	respiratory diseases	comorbid conditions	chronic lung disease	overload	myocardial injury	hemodynamic instability	cancers	hemostasis	consequences	several factors	vascular risk factors	pathological conditions	co-morbidities	organs	adulthood	risk factor	autoimmune disease	fluids	serious complications	many factors	tobacco smoke	pulmonary diseases	traditional risk factors	cause	neurodegenerative diseases	surgical interventions	symptoms	parameters	allergic diseases	chronic conditions	multiple factors	important factors	chronic inflammatory diseases	clinical conditions	lung diseases	peripheral neuropathy	outcome measures	respiratory complications	mechanisms	vascular diseases	clinical factors	protein	chemotherapeutic agents	expressions	somatic symptoms	disease states	human diseases	soft tissues	subclinical atherosclerosis	Disorders	etiologies	metabolic diseases	health outcomes	medical conditions	severe outcomes	important risk factors	systemic effects	lung transplant	severe complications	volume overload	atherothrombosis	systemic diseases	body fluids	autoimmune disorders	insults	characteristics	treatments	Comorbidities	inflammatory factors	comorbidities	immobility	symptoms	cancers	hypercoagulability	complications	demographic factors	structural heart disease	different diseases	respiratory problems	primary headaches	multiple comorbidities	biological processes	bone diseases	mechanisms	malignancy	cancer types	cardiac risk factors	etiologies	various cancers	host factors	constitutional symptoms	microvascular disease	cardiovascular disorders	chronic inflammatory conditions	comorbidity	bone-targeted agents	airway diseases	potential complications	cardiac conditions	fluid overload	several diseases	pathologic conditions	inotropes	non-specific symptoms	Other variables	chronic diseases	lifestyle habits	neurological conditions	risk groups	neurotransmitters	osteoclast function	systemic factors	allergic disorders	barotrauma	major adverse events	meningeal irritation	rare diseases	immune dysregulation	nonspecific symptoms	approaches	ischemic conditions	many diseases	tumours	various diseases	agents	biological fluids	cardiovascular symptoms	tumors	another disorder	multiple risk factors	peripheral tissues	additional risk factors	invasive mechanical ventilation	metabolic dysfunction	novel approaches	precipitants	Environmental factors	tissues	carcinogens	painful conditions	regulatory proteins	additional factors	causative factors	different tumors	possible confounders	left heart disease	severe diseases	autonomic regulation	complex disease	secondary effects	threats	underlying conditions	various malignancies	Other risk factors	illnesses	significant comorbidities	Primary headaches	atherosclerotic risk factors	clinical outcomes	obstructive lung diseases	abnormalities	certain situations	long-term side effects	neurovascular headaches	specific diseases	Bone-targeted agents	different stimuli	intracranial lesions	common comorbidities	exogenous sources	sensory symptoms	antiresorptive agents	co-morbid conditions	metabolic bone diseases	objective signs	obstructive lung disease	physiological responses	primary headache disorders	related conditions	secreted proteins	underlying diseases	vascular risk factors	All factors	cardiac manifestations	chronic inflammatory condition	chronic medical conditions	clinical details	comorbid condition	functional outcomes	increased sympathetic activity	multifactorial diseases	peripheral neuropathies	proinflammatory conditions	various complications	acute respiratory events	certain risk factors	emotional factors	epidemiologic risk factors	neuropsychiatric manifestations	non-communicable diseases	patient-centered outcomes	side effects	significant symptoms	smoking-related diseases	various disorders	All variables	Other complications	anastomotic leak	antecedent events	biofluids	chronic health conditions	co-morbidities	life style factors	noncommunicable diseases	serious diseases	vascular conditions	Post-operative complications	ailments	anti-resorptive agents	categorical predictors	chronic lung disease	different variables	excessive bone resorption	medical comorbidity	obesity-related diseases	significant complications	Clinical conditions	Outcomes	bone resorption inhibitors	cellular responses	central nervous system manifestations	chronic comorbidities	chronic inflammatory lung diseases	high-risk subgroups	lifestyle-related diseases	acute conditions	benign entities	chronic respiratory diseases	co-morbid diseases	degenerative diseases	hormone-dependent cancers	immunocompromised hosts	insult	interventricular delay	lifestyle exposures	many tumours	possible problems	post-operative complications	potent bone-targeted agents	pulmonary disorders	secondary repolarization abnormalities	serious disorders	solid tumour	specific headache types	substantial risk	systemic circulation	tumor types	Negative emotional states	Non-specific symptoms	adverse health effects	chronic respiratory illnesses	common source	disease-associated factors	experimental interventions	external signals	frequent adverse events	intravenous contrast	non-cardiovascular co-morbidities	non-specific constitutional symptoms	pathologies	systemic pathologies	COPD-related diseases	Somatic symptoms	afflictions	anti-resorptive drugs	biologic substances	blood inflammatory markers	certain cancer types	certain disease	chronic medical conditions	co-existing diseases	concomitant illnesses	constitutional symptoms	diagnostic specimens	disease areas	diverse disorders	experiential phenomena	explanatory variables	foreign materials	gastric complications	heterogeneous entities	important symptom	incident cardiovascular disease events	inflammatory cytokines	inflammatory respiratory diseases	injectable biological fluids	irreversible events	irreversible results	lung conditions	medical complications	medication	mild side effects	non-atherosclerotic etiology	osteoclast-targeting agents	pacemaker function	paroxysmal disorder	pathological settings	perioperative side effects	postprocedural complications	prevalent pulmonary diseases	pulmonary illness	relevant processes	self-perceived aspects	several cardiovascular conditions	significant co morbidity	special diseases	surrogate tissue	systemic bone-targeted agents	vasopressin production	AO-related areas	Complex diseases	IgE-dependent diseases	Mechanical parameters	No major acute complications	Pre-operative risk factors	Short-term risks	Some perceived barriers	Th2-related disease	The standard risk factors	Traditional drugs	acute event	acute thromboembolic events	additional cardiovascular co-morbidities	additional headache types	address lifestyle factors	adequate means	administrative characteristics	age-related comorbidities	age-related problems	airway inflammations	and/or neurological symptoms	another primary head- ache disorder	arrhythmic risk factors	asymptomatic chronic diseases	biochemistry factors	biological state	bone osteolysis	bone-related disorders	bronchial etiologies	cardiovascular diseases	cardiovascular risk comorbidities	certain common symptoms	chronic airway inflammatory diseases	chronic autoimmune diseases	chronic lung conditions	chronic medical condition	chronic obstructive lung diseases	chronic pulmonary disorders	classic cardiovascular risk factors	co-existing systemic disease	common comorbid conditions	common headaches	community-acquired infections	comobidities	comparable samples	complex disorders	complex genetic disorder	concomitant inflammatory diseases	current additional allergic symptoms	current medical conditions	different carcinoma localizations	different clinical setting	different environmental exposures	different target organs	diffuse ischemia	driven diseases	energy intake disease conditions	event risks	exhibits several COPD-associated co-morbidities	experience side effects	frequent co-morbidities,43	gastrointestinal complications	generalized vascular pathology	high comorbidity	high device-related complications	high oxidative capacity	high-risk features	higher-risk features	human airways diseases	ictal phenomena	important co-morbidites	important comorbidities	inflammatory lung diseases	influence processes	insulin-sensitive organs	irritative sensory features	long term support complications	long-term pulmonary impairments	longer-term complications	low-incidence complications	major atherosclerotic macrovascular events	major diseases	major inflammatory diseases	major medical illnesses	many connective tissue diseases	many consequences	many immune-related diseases	mental states	microtubule-targeted drugs	migraine trigger	multi-factorial disorder	multiple significant adverse reactions	negative factors	non-smokers.18 Other lifestyle factors	nonemotional characteristics	nonspecific complaints	normal disease tissues	normal physiologic processes	organ toxicities	osteolytic bone conditions	others diseases	palliative care symptoms	pathologic tissue destruction	permanent serious disease	physical barriers	possessed risk factors	potent biochemical mediators	pre-existing chronic diseases	pressure symptoms	primary head syndromes	primary headache category	primary outcomes	primary sites	prior non-malignant lung disease	progenitor states	proper cell lineages	relevant entity	respiratory system events	score,43 comorbidities	secondary dyslipidemias	significant inflammatory component	similar circumstances	skeletal muscle injuries	smoking hazards	soft tissue involvement	special medications	specific physical stimuli	strong vascular risk factors	systematic status	tissue symptoms	tongue symptoms	typical neurological clinical presentations	unrecognised.1 Characteristics	usual cardiovascular risk factors	various cancer entities	various health-related issues	various respiratory health problems	vascular pain syndromes	well-known adolescent public health problems	well-known pathologies	young adult mice	’ prenatal history	“ anti-resorptive ” agents
treatment	cases	disease	risk	cancer	inflammation	symptoms	breast cancer	function	infection	heart failure	pain	therapy	asthma	factors	patient	risk factors	blood	complications	cardiovascular disease	tumors	stimulation	conditions	lung cancer	progression	parameters	factor	stress	experience	heart	outcomes	events	lung	variables	techniques	areas	diseases	findings	comorbidities	lymphoma	methods	proteins	infections	bone resorption	illness	cardiovascular events	sites	agents	endothelial dysfunction	functions	syncope	risks	side effects	adverse events	respiratory failure	bisphosphonates	medications	inflammatory mediators	cardiovascular diseases	cardiovascular risk factors	headache disorders	lung disease	metabolic syndrome	skeletal muscle	surgeons	factors	systemic inflammation	chronic inflammation	consequences	childhood	clinical features	processes	modalities	Factors	therapies	metabolic syndrome	causes	autoimmune diseases	malignancies	coagulation	inflammatory diseases	adult patients	approaches	disease	states	diseases	organs	chronic diseases	pathways	Risk factors	habits	risk factors	clinical parameters	patient characteristics	vasculitis	abuse	neurological disorders	complication	complaints	conditions	environmental factors	respiratory diseases	comorbid conditions	chronic lung disease	overload	myocardial injury	hemostasis	consequences	several factors	vascular risk factors	pathological conditions	co-morbidities	organs	risk factor	autoimmune disease	fluids	serious complications	many factors	tobacco smoke	pulmonary diseases	cause	neurodegenerative diseases	surgical interventions	symptoms	parameters	allergic diseases	chronic conditions	multiple factors	chronic inflammatory diseases	clinical conditions	lung diseases	peripheral neuropathy	outcome measures	respiratory complications	mechanisms	vascular diseases	clinical factors	protein	chemotherapeutic agents	expressions	somatic symptoms	disease states	human diseases	soft tissues	subclinical atherosclerosis	Disorders	etiologies	metabolic diseases	medical conditions	severe outcomes	important risk factors	systemic effects	lung transplant	volume overload	atherothrombosis	systemic diseases	body fluids	autoimmune disorders	insults	characteristics	treatments	Comorbidities	inflammatory factors	comorbidities	immobility	cancers	hypercoagulability	complications	demographic factors	sotalol	structural heart disease	different diseases	respiratory problems	multiple comorbidities	biological processes	bone diseases	mechanisms	malignancy	cardiac risk factors	etiologies	various cancers	host factors	constitutional symptoms	microvascular disease	cardiovascular disorders	chronic inflammatory conditions	comorbidity	bone-targeted agents	airway diseases	potential complications	cardiac conditions	fluid overload	pathologic conditions	non-specific symptoms	Other variables	chronic diseases	lifestyle habits	neurological conditions	risk groups	osteoclast function	systemic factors	allergic disorders	major adverse events	rare diseases	immune dysregulation	nonspecific symptoms	approaches	ischemic conditions	many diseases	tumours	various diseases	agents	biological fluids	cardiovascular symptoms	tumors	another disorder	multiple risk factors	peripheral tissues	metabolic dysfunction	novel approaches	precipitants	Environmental factors	tissues	carcinogens	painful conditions	additional factors	causative factors	different tumors	possible confounders	left heart disease	severe diseases	autonomic regulation	complex disease	secondary effects	threats	underlying conditions	various malignancies	Other risk factors	illnesses	significant comorbidities	atherosclerotic risk factors	clinical outcomes	obstructive lung diseases	certain situations	long-term side effects	specific diseases	Bone-targeted agents	common comorbidities	exogenous sources	sensory symptoms	antiresorptive agents	co-morbid conditions	metabolic bone diseases	objective signs	obstructive lung disease	physiological responses	related conditions	underlying diseases	vascular risk factors	All factors	cardiac manifestations	chronic inflammatory condition	chronic medical conditions	clinical details	comorbid condition	increased sympathetic activity	multifactorial diseases	peripheral neuropathies	various complications	acute respiratory events	certain risk factors	emotional factors	epidemiologic risk factors	neuropsychiatric manifestations	non-communicable diseases	patient-centered outcomes	side effects	significant symptoms	smoking-related diseases	All variables	Other complications	antecedent events	biofluids	chronic health conditions	co-morbidities	life style factors	noncommunicable diseases	serious diseases	Post-operative complications	ailments	anti-resorptive agents	categorical predictors	chronic lung disease	different variables	excessive bone resorption	medical comorbidity	obesity-related diseases	significant complications	Clinical conditions	Outcomes	bone resorption inhibitors	cellular responses	chronic inflammatory lung diseases	acute conditions	benign entities	chronic respiratory diseases	co-morbid diseases	degenerative diseases	hormone-dependent cancers	immunocompromised hosts	insult	interventricular delay	lifestyle exposures	possible problems	post-operative complications	potent bone-targeted agents	pulmonary disorders	secondary repolarization abnormalities	serious disorders	solid tumour	substantial risk	Negative emotional states	adverse health effects	chronic respiratory illnesses	common source	disease-associated factors	experimental interventions	external signals	frequent adverse events	intravenous contrast	non-cardiovascular co-morbidities	non-specific constitutional symptoms	pathologies	systemic pathologies	COPD-related diseases	afflictions	anti-resorptive drugs	blood inflammatory markers	certain cancer types	certain disease	chronic medical conditions	co-existing diseases	concomitant illnesses	constitutional symptoms	diagnostic specimens	disease areas	diverse disorders	experiential phenomena	explanatory variables	foreign materials	gastric complications	heterogeneous entities	important symptom	incident cardiovascular disease events	inflammatory cytokines	inflammatory respiratory diseases	injectable biological fluids	irreversible events	irreversible results	lung conditions	medical complications	medication	non-atherosclerotic etiology	osteoclast-targeting agents	pacemaker function	pathological settings	perioperative side effects	postprocedural complications	prevalent pulmonary diseases	pulmonary illness	relevant processes	self-perceived aspects	several cardiovascular conditions	significant co morbidity	special diseases	surrogate tissue	systemic bone-targeted agents	vasopressin production	AO-related areas	Complex diseases	IgE-dependent diseases	Mechanical parameters	No major acute complications	Short-term risks	Some perceived barriers	Th2-related disease	The standard risk factors	Traditional drugs	acute event	acute thromboembolic events	address lifestyle factors	adequate means	administrative characteristics	age-related comorbidities	age-related problems	airway inflammations	arrhythmic risk factors	asymptomatic chronic diseases	biological state	bone osteolysis	bone-related disorders	bronchial etiologies	cardiovascular diseases	cardiovascular risk comorbidities	certain common symptoms	chronic airway inflammatory diseases	chronic autoimmune diseases	chronic lung conditions	chronic medical condition	chronic obstructive lung diseases	chronic pulmonary disorders	co-existing systemic disease	common comorbid conditions	community-acquired infections	comobidities	comparable samples	complex disorders	concomitant inflammatory diseases	current additional allergic symptoms	current medical conditions	different carcinoma localizations	different clinical setting	different environmental exposures	different target organs	diffuse ischemia	driven diseases	energy intake disease conditions	event risks	exhibits several COPD-associated co-morbidities	experience side effects	frequent co-morbidities,43	gastrointestinal complications	generalized vascular pathology	high comorbidity	high device-related complications	high oxidative capacity	high-risk features	human airways diseases	ictal phenomena	important comorbidities	inflammatory lung diseases	influence processes	insulin-sensitive organs	irritative sensory features	long term support complications	long-term pulmonary impairments	longer-term complications	major atherosclerotic macrovascular events	major diseases	major inflammatory diseases	major medical illnesses	many connective tissue diseases	many consequences	many immune-related diseases	mental states	microtubule-targeted drugs	migraine trigger	multi-factorial disorder	multiple significant adverse reactions	negative factors	non-smokers.18 Other lifestyle factors	nonemotional characteristics	normal physiologic processes	organ toxicities	osteolytic bone conditions	others diseases	palliative care symptoms	pathologic tissue destruction	permanent serious disease	physical barriers	possessed risk factors	pre-existing chronic diseases	primary sites	prior non-malignant lung disease	progenitor states	proper cell lineages	relevant entity	respiratory system events	significant inflammatory component	similar circumstances	skeletal muscle injuries	smoking hazards	soft tissue involvement	specific physical stimuli	systematic status	tissue symptoms	tongue symptoms	unrecognised.1 Characteristics	usual cardiovascular risk factors	various health-related issues	various respiratory health problems	well-known adolescent public health problems	well-known pathologies	young adult mice	’ prenatal history	“ anti-resorptive ” agents
treatment	disease	cancer	inflammation	breast cancer	function	therapy	asthma	factors	patient	risk factors	blood	complications	stimulation	conditions	lung cancer	progression	stress	experience	outcomes	lung	variables	techniques	areas	diseases	comorbidities	methods	proteins	infections	bone resorption	illness	sites	agents	functions	respiratory failure	bisphosphonates	medications	inflammatory mediators	lung disease	metabolic syndrome	skeletal muscle	systemic inflammation	chronic inflammation	childhood	clinical features	processes	modalities	therapies	malignancies	coagulation	inflammatory diseases	approaches	disease	states	diseases	organs	chronic diseases	pathways	risk factors	patient characteristics	vasculitis	abuse	neurological disorders	complication	conditions	environmental factors	respiratory diseases	chronic lung disease	overload	hemostasis	several factors	pathological conditions	organs	fluids	many factors	tobacco smoke	pulmonary diseases	neurodegenerative diseases	parameters	allergic diseases	chronic conditions	multiple factors	clinical conditions	lung diseases	mechanisms	protein	expressions	disease states	soft tissues	Disorders	systemic effects	atherothrombosis	body fluids	insults	treatments	Comorbidities	inflammatory factors	comorbidities	cancers	respiratory problems	biological processes	bone diseases	etiologies	various cancers	host factors	chronic inflammatory conditions	bone-targeted agents	airway diseases	fluid overload	non-specific symptoms	Other variables	syphilis	osteoclast function	systemic factors	allergic disorders	rare diseases	approaches	many diseases	tumours	various diseases	biological fluids	tumors	peripheral tissues	novel approaches	precipitants	Environmental factors	tissues	painful conditions	different tumors	severe diseases	complex disease	secondary effects	underlying conditions	various malignancies	Other risk factors	obstructive lung diseases	long-term side effects	specific diseases	Bone-targeted agents	antiresorptive agents	co-morbid conditions	metabolic bone diseases	objective signs	obstructive lung disease	physiological responses	underlying diseases	clinical details	multifactorial diseases	emotional factors	epidemiologic risk factors	side effects	smoking-related diseases	biofluids	chronic health conditions	life style factors	serious diseases	Post-operative complications	anti-resorptive agents	chronic lung disease	different variables	excessive bone resorption	obesity-related diseases	Clinical conditions	bone resorption inhibitors	cellular responses	chronic inflammatory lung diseases	chronic respiratory diseases	degenerative diseases	hormone-dependent cancers	interventricular delay	potent bone-targeted agents	pulmonary disorders	serious disorders	solid tumour	Negative emotional states	adverse health effects	chronic respiratory illnesses	common source	disease-associated factors	experimental interventions	frequent adverse events	intravenous contrast	non-cardiovascular co-morbidities	pathologies	afflictions	anti-resorptive drugs	blood inflammatory markers	certain cancer types	certain disease	chronic medical conditions	co-existing diseases	concomitant illnesses	diagnostic specimens	disease areas	diverse disorders	experiential phenomena	foreign materials	inflammatory cytokines	inflammatory respiratory diseases	injectable biological fluids	irreversible events	irreversible results	lung conditions	medication	non-atherosclerotic etiology	osteoclast-targeting agents	pacemaker function	perioperative side effects	prevalent pulmonary diseases	pulmonary illness	relevant processes	significant co morbidity	surrogate tissue	systemic bone-targeted agents	AO-related areas	Complex diseases	IgE-dependent diseases	Mechanical parameters	Some perceived barriers	Th2-related disease	Traditional drugs	address lifestyle factors	adequate means	age-related problems	airway inflammations	bacteria infections	biological state	bone osteolysis	bone-related disorders	bronchial etiologies	chronic airway inflammatory diseases	chronic lung conditions	chronic obstructive lung diseases	chronic pulmonary disorders	comobidities	current additional allergic symptoms	different carcinoma localizations	different target organs	driven diseases	energy intake disease conditions	high comorbidity	high device-related complications	human airways diseases	inflammatory lung diseases	influence processes	insulin-sensitive organs	long-term pulmonary impairments	major diseases	major inflammatory diseases	major medical illnesses	many consequences	mental states	migraine trigger	multi-factorial disorder	multiple significant adverse reactions	negative factors	non-smokers.18 Other lifestyle factors	normal physiologic processes	others diseases	pathologic tissue destruction	physical barriers	possessed risk factors	primary sites	prior non-malignant lung disease	proper cell lineages	relevant entity	respiratory system events	skeletal muscle injuries	smoking hazards	specific physical stimuli	systematic status	various health-related issues	various respiratory health problems	well-known adolescent public health problems	young adult mice	“ anti-resorptive ” agents
treatment	disease	cancer	inflammation	symptoms	breast cancer	function	therapy	asthma	factors	patient	risk factors	blood	complications	stimulation	conditions	lung cancer	progression	stress	experience	outcomes	lung	variables	techniques	areas	diseases	comorbidities	methods	proteins	infections	bone resorption	illness	sites	agents	functions	respiratory failure	bisphosphonates	medications	inflammatory mediators	lung disease	metabolic syndrome	skeletal muscle	systemic inflammation	chronic inflammation	childhood	clinical features	processes	modalities	therapies	malignancies	coagulation	inflammatory diseases	approaches	disease	states	diseases	organs	chronic diseases	pathways	risk factors	clinical parameters	patient characteristics	vasculitis	abuse	neurological disorders	complication	conditions	environmental factors	respiratory diseases	chronic lung disease	overload	hemostasis	several factors	pathological conditions	organs	fluids	many factors	tobacco smoke	pulmonary diseases	neurodegenerative diseases	parameters	allergic diseases	chronic conditions	multiple factors	clinical conditions	lung diseases	mechanisms	protein	expressions	disease states	soft tissues	Disorders	systemic effects	atherothrombosis	body fluids	insults	characteristics	treatments	Comorbidities	inflammatory factors	comorbidities	cancers	respiratory problems	biological processes	bone diseases	etiologies	various cancers	host factors	chronic inflammatory conditions	bone-targeted agents	airway diseases	fluid overload	non-specific symptoms	Other variables	osteoclast function	systemic factors	allergic disorders	rare diseases	otalgia	approaches	many diseases	tumours	various diseases	biological fluids	tumors	peripheral tissues	novel approaches	precipitants	Environmental factors	tissues	painful conditions	different tumors	severe diseases	complex disease	secondary effects	underlying conditions	various malignancies	Other risk factors	clinical outcomes	obstructive lung diseases	long-term side effects	specific diseases	Bone-targeted agents	antiresorptive agents	co-morbid conditions	metabolic bone diseases	objective signs	obstructive lung disease	physiological responses	underlying diseases	clinical details	multifactorial diseases	emotional factors	epidemiologic risk factors	patient-centered outcomes	side effects	smoking-related diseases	biofluids	chronic health conditions	life style factors	serious diseases	Post-operative complications	anti-resorptive agents	chronic lung disease	different variables	excessive bone resorption	obesity-related diseases	Clinical conditions	bone resorption inhibitors	cellular responses	chronic inflammatory lung diseases	chronic respiratory diseases	degenerative diseases	hormone-dependent cancers	interventricular delay	potent bone-targeted agents	pulmonary disorders	serious disorders	solid tumour	Negative emotional states	adverse health effects	chronic respiratory illnesses	common source	disease-associated factors	experimental interventions	frequent adverse events	intravenous contrast	non-cardiovascular co-morbidities	pathologies	afflictions	anti-resorptive drugs	blood inflammatory markers	certain cancer types	certain disease	chronic medical conditions	co-existing diseases	concomitant illnesses	diagnostic specimens	disease areas	diverse disorders	experiential phenomena	explanatory variables	foreign materials	inflammatory cytokines	inflammatory respiratory diseases	injectable biological fluids	irreversible events	irreversible results	lung conditions	medication	non-atherosclerotic etiology	osteoclast-targeting agents	otologic symptoms	pacemaker function	perioperative side effects	prevalent pulmonary diseases	pulmonary illness	relevant processes	self-perceived aspects	significant co morbidity	surrogate tissue	systemic bone-targeted agents	AO-related areas	Complex diseases	IgE-dependent diseases	Mechanical parameters	Some perceived barriers	Th2-related disease	Traditional drugs	address lifestyle factors	adequate means	age-related problems	airway inflammations	biological state	bone osteolysis	bone-related disorders	bronchial etiologies	chronic airway inflammatory diseases	chronic lung conditions	chronic obstructive lung diseases	chronic pulmonary disorders	comobidities	current additional allergic symptoms	different carcinoma localizations	different target organs	driven diseases	energy intake disease conditions	high comorbidity	high device-related complications	human airways diseases	inflammatory lung diseases	influence processes	insulin-sensitive organs	long-term pulmonary impairments	major diseases	major inflammatory diseases	major medical illnesses	many consequences	mental states	migraine trigger	multi-factorial disorder	multiple significant adverse reactions	negative factors	non-smokers.18 Other lifestyle factors	normal physiologic processes	others diseases	otologic symptoms	pathologic tissue destruction	physical barriers	possessed risk factors	primary sites	prior non-malignant lung disease	proper cell lineages	relevant entity	respiratory system events	skeletal muscle injuries	smoking hazards	specific physical stimuli	systematic status	various health-related issues	various respiratory health problems	well-known adolescent public health problems	young adult mice	“ anti-resorptive ” agents
treatment	disease	cancer	inflammation	symptoms	breast cancer	function	infection	heart failure	pain	therapy	asthma	factors	patient	risk factors	blood	complications	cardiovascular disease	tumors	stimulation	conditions	lung cancer	progression	parameters	stress	experience	heart	outcomes	events	lung	variables	techniques	areas	diseases	comorbidities	lymphoma	methods	proteins	infections	bone resorption	illness	sites	agents	endothelial dysfunction	functions	syncope	risks	side effects	adverse events	respiratory failure	bisphosphonates	medications	inflammatory mediators	cardiovascular diseases	cardiovascular risk factors	headache disorders	lung disease	metabolic syndrome	skeletal muscle	systemic inflammation	chronic inflammation	childhood	clinical features	processes	modalities	Factors	therapies	metabolic syndrome	causes	autoimmune diseases	malignancies	coagulation	inflammatory diseases	adult patients	approaches	disease	states	diseases	organs	chronic diseases	pathways	Risk factors	habits	risk factors	clinical parameters	patient characteristics	vasculitis	abuse	neurological disorders	complication	complaints	conditions	environmental factors	respiratory diseases	comorbid conditions	chronic lung disease	overload	hemostasis	consequences	several factors	vascular risk factors	pathological conditions	co-morbidities	organs	autoimmune disease	fluids	serious complications	many factors	tobacco smoke	pulmonary diseases	cause	neurodegenerative diseases	surgical interventions	symptoms	parameters	allergic diseases	chronic conditions	multiple factors	chronic inflammatory diseases	clinical conditions	lung diseases	peripheral neuropathy	respiratory complications	mechanisms	vascular diseases	clinical factors	protein	expressions	somatic symptoms	disease states	human diseases	soft tissues	subclinical atherosclerosis	Disorders	etiologies	metabolic diseases	severe outcomes	systemic effects	lung transplant	volume overload	atherothrombosis	systemic diseases	body fluids	autoimmune disorders	insults	characteristics	treatments	Comorbidities	inflammatory factors	comorbidities	cancers	hypercoagulability	complications	demographic factors	respiratory problems	multiple comorbidities	biological processes	bone diseases	mechanisms	malignancy	cardiac risk factors	etiologies	various cancers	host factors	constitutional symptoms	chronic inflammatory conditions	comorbidity	bone-targeted agents	airway diseases	potential complications	cardiac conditions	fluid overload	pathologic conditions	non-specific symptoms	orthopnea	Other variables	chronic diseases	neurological conditions	osteoclast function	systemic factors	allergic disorders	major adverse events	rare diseases	immune dysregulation	nonspecific symptoms	approaches	ischemic conditions	many diseases	tumours	various diseases	biological fluids	cardiovascular symptoms	tumors	another disorder	peripheral tissues	metabolic dysfunction	novel approaches	precipitants	Environmental factors	tissues	painful conditions	additional factors	different tumors	possible confounders	left heart disease	severe diseases	autonomic regulation	complex disease	secondary effects	threats	underlying conditions	various malignancies	Other risk factors	illnesses	significant comorbidities	atherosclerotic risk factors	clinical outcomes	obstructive lung diseases	certain situations	long-term side effects	specific diseases	Bone-targeted agents	common comorbidities	sensory symptoms	antiresorptive agents	co-morbid conditions	metabolic bone diseases	objective signs	obstructive lung disease	physiological responses	underlying diseases	vascular risk factors	All factors	cardiac manifestations	chronic inflammatory condition	chronic medical conditions	clinical details	comorbid condition	increased sympathetic activity	multifactorial diseases	peripheral neuropathies	various complications	acute respiratory events	certain risk factors	emotional factors	epidemiologic risk factors	neuropsychiatric manifestations	patient-centered outcomes	side effects	significant symptoms	smoking-related diseases	All variables	Other complications	antecedent events	biofluids	chronic health conditions	life style factors	noncommunicable diseases	serious diseases	Post-operative complications	ailments	anti-resorptive agents	categorical predictors	chronic lung disease	different variables	excessive bone resorption	medical comorbidity	obesity-related diseases	significant complications	Clinical conditions	Outcomes	bone resorption inhibitors	cellular responses	chronic inflammatory lung diseases	benign entities	chronic respiratory diseases	co-morbid diseases	degenerative diseases	hormone-dependent cancers	insult	interventricular delay	possible problems	post-operative complications	potent bone-targeted agents	pulmonary disorders	serious disorders	solid tumour	substantial risk	Negative emotional states	adverse health effects	chronic respiratory illnesses	common source	disease-associated factors	experimental interventions	external signals	frequent adverse events	intravenous contrast	non-cardiovascular co-morbidities	non-specific constitutional symptoms	pathologies	systemic pathologies	COPD-related diseases	afflictions	anti-resorptive drugs	blood inflammatory markers	certain cancer types	certain disease	chronic medical conditions	co-existing diseases	concomitant illnesses	constitutional symptoms	diagnostic specimens	disease areas	diverse disorders	experiential phenomena	explanatory variables	foreign materials	gastric complications	heterogeneous entities	important symptom	incident cardiovascular disease events	inflammatory cytokines	inflammatory respiratory diseases	injectable biological fluids	irreversible events	irreversible results	lung conditions	medical complications	medication	non-atherosclerotic etiology	osteoclast-targeting agents	pacemaker function	pathological settings	perioperative side effects	postprocedural complications	prevalent pulmonary diseases	pulmonary illness	relevant processes	self-perceived aspects	several cardiovascular conditions	significant co morbidity	special diseases	surrogate tissue	systemic bone-targeted agents	vasopressin production	AO-related areas	Complex diseases	IgE-dependent diseases	Mechanical parameters	No major acute complications	Short-term risks	Some perceived barriers	Th2-related disease	The standard risk factors	Traditional drugs	acute event	address lifestyle factors	adequate means	administrative characteristics	age-related comorbidities	age-related problems	airway inflammations	arrhythmic risk factors	biological state	bone osteolysis	bone-related disorders	bronchial etiologies	cardiovascular diseases	certain common symptoms	chronic airway inflammatory diseases	chronic autoimmune diseases	chronic lung conditions	chronic medical condition	chronic obstructive lung diseases	chronic pulmonary disorders	co-existing systemic disease	common comorbid conditions	community-acquired infections	comobidities	complex disorders	concomitant inflammatory diseases	current additional allergic symptoms	current medical conditions	different carcinoma localizations	different clinical setting	different environmental exposures	different target organs	driven diseases	energy intake disease conditions	exhibits several COPD-associated co-morbidities	experience side effects	frequent co-morbidities,43	gastrointestinal complications	generalized vascular pathology	high comorbidity	high device-related complications	high oxidative capacity	high-risk features	human airways diseases	important comorbidities	inflammatory lung diseases	influence processes	insulin-sensitive organs	irritative sensory features	long term support complications	long-term pulmonary impairments	longer-term complications	major diseases	major inflammatory diseases	major medical illnesses	many connective tissue diseases	many consequences	many immune-related diseases	mental states	migraine trigger	multi-factorial disorder	multiple significant adverse reactions	negative factors	non-smokers.18 Other lifestyle factors	nonemotional characteristics	normal physiologic processes	organ toxicities	osteolytic bone conditions	others diseases	palliative care symptoms	pathologic tissue destruction	physical barriers	possessed risk factors	pre-existing chronic diseases	primary sites	prior non-malignant lung disease	progenitor states	proper cell lineages	relevant entity	respiratory system events	similar circumstances	skeletal muscle injuries	smoking hazards	soft tissue involvement	specific physical stimuli	systematic status	tissue symptoms	tongue symptoms	unrecognised.1 Characteristics	various health-related issues	various respiratory health problems	well-known adolescent public health problems	well-known pathologies	young adult mice	’ prenatal history	“ anti-resorptive ” agents
cancer	inflammation	therapy	blood	complications	stimulation	techniques	methods	proteins	illness	agents	functions	bisphosphonates	inflammatory mediators	processes	modalities	therapies	malignancies	coagulation	acute respiratory failure	approaches	disease	states	diseases	pathways	risk factors	vasculitis	abuse	neurological disorders	complication	environmental factors	hemostasis	fluids	multiple factors	mechanisms	soft tissues	atherothrombosis	body fluids	inflammatory factors	cancers	biological processes	bone-targeted agents	non-specific symptoms	Other variables	osteoclast function	systemic factors	approaches	biological fluids	painful conditions	severe diseases	secondary effects	Other risk factors	Bone-targeted agents	antiresorptive agents	co-morbid conditions	objective signs	physiological responses	emotional factors	epidemiologic risk factors	side effects	smoking-related diseases	biofluids	life style factors	serious diseases	anti-resorptive agents	obesity-related diseases	bone resorption inhibitors	cellular responses	degenerative diseases	potent bone-targeted agents	serious disorders	Negative emotional states	adverse health effects	non-cardiovascular co-morbidities	pathologies	afflictions	anti-resorptive drugs	blood inflammatory markers	certain disease	concomitant illnesses	diagnostic specimens	disease areas	foreign materials	inflammatory cytokines	injectable biological fluids	irreversible events	medication	non-atherosclerotic etiology	osteoclast-targeting agents	pacemaker function	relevant processes	significant co morbidity	surrogate tissue	systemic bone-targeted agents	AO-related areas	Traditional drugs	adequate means	biological state	comobidities	energy intake disease conditions	influence processes	major diseases	major medical illnesses	many consequences	multiple significant adverse reactions	non-smokers.18 Other lifestyle factors	normal physiologic processes	others diseases	pathologic tissue destruction	proper cell lineages	skeletal muscle injuries	“ anti-resorptive ” agents
disease	cancer	inflammation	function	therapy	asthma	factors	patient	risk factors	blood	complications	stimulation	conditions	lung cancer	progression	experience	outcomes	lung	techniques	diseases	comorbidities	methods	proteins	bone resorption	illness	sites	agents	functions	respiratory failure	bisphosphonates	inflammatory mediators	lung disease	metabolic syndrome	skeletal muscle	chronic inflammation	childhood	clinical features	processes	modalities	therapies	malignancies	coagulation	inflammatory diseases	approaches	disease	states	diseases	organs	chronic diseases	pathways	risk factors	vasculitis	abuse	neurological disorders	complication	conditions	environmental factors	respiratory diseases	chronic lung disease	hemostasis	pathological conditions	organs	fluids	tobacco smoke	pulmonary diseases	neurodegenerative diseases	parameters	allergic diseases	chronic conditions	multiple factors	lung diseases	mechanisms	protein	disease states	soft tissues	Disorders	systemic effects	atherothrombosis	body fluids	Comorbidities	inflammatory factors	comorbidities	cancers	respiratory problems	biological processes	bone diseases	various cancers	host factors	bone-targeted agents	airway diseases	fluid overload	non-specific symptoms	Other variables	osteoclast function	systemic factors	allergic disorders	rare diseases	approaches	tumours	biological fluids	peripheral tissues	tissues	painful conditions	different tumors	severe diseases	secondary effects	underlying conditions	various malignancies	Other risk factors	obstructive lung diseases	long-term side effects	specific diseases	Bone-targeted agents	antiresorptive agents	co-morbid conditions	metabolic bone diseases	objective signs	obstructive lung disease	physiological responses	underlying diseases	abortion	multifactorial diseases	emotional factors	epidemiologic risk factors	side effects	smoking-related diseases	biofluids	chronic health conditions	life style factors	serious diseases	Post-operative complications	anti-resorptive agents	chronic lung disease	different variables	excessive bone resorption	obesity-related diseases	Clinical conditions	bone resorption inhibitors	cellular responses	chronic inflammatory lung diseases	chronic respiratory diseases	degenerative diseases	interventricular delay	potent bone-targeted agents	pulmonary disorders	serious disorders	solid tumour	Negative emotional states	adverse health effects	chronic respiratory illnesses	experimental interventions	non-cardiovascular co-morbidities	pathologies	afflictions	anti-resorptive drugs	blood inflammatory markers	certain cancer types	certain disease	chronic medical conditions	co-existing diseases	concomitant illnesses	diagnostic specimens	disease areas	diverse disorders	foreign materials	inflammatory cytokines	inflammatory respiratory diseases	injectable biological fluids	irreversible events	irreversible results	lung conditions	medication	non-atherosclerotic etiology	osteoclast-targeting agents	pacemaker function	prevalent pulmonary diseases	pulmonary illness	relevant processes	significant co morbidity	surrogate tissue	systemic bone-targeted agents	AO-related areas	Complex diseases	IgE-dependent diseases	Th2-related disease	Traditional drugs	adequate means	age-related problems	airway inflammations	biological state	bone-related disorders	bronchial etiologies	chronic airway inflammatory diseases	chronic lung conditions	chronic obstructive lung diseases	chronic pulmonary disorders	comobidities	current additional allergic symptoms	different target organs	driven diseases	energy intake disease conditions	high comorbidity	human airways diseases	inflammatory lung diseases	influence processes	insulin-sensitive organs	long-term pulmonary impairments	major diseases	major inflammatory diseases	major medical illnesses	many consequences	multi-factorial disorder	multiple significant adverse reactions	negative factors	non-smokers.18 Other lifestyle factors	normal physiologic processes	others diseases	pathologic tissue destruction	physical barriers	possessed risk factors	primary sites	prior non-malignant lung disease	proper cell lineages	relevant entity	respiratory system events	skeletal muscle injuries	smoking hazards	systematic status	various health-related issues	various respiratory health problems	well-known adolescent public health problems	young adult mice	“ anti-resorptive ” agents
treatment	disease	cancer	inflammation	symptoms	breast cancer	function	therapy	asthma	factors	patient	risk factors	blood	complications	stimulation	conditions	lung cancer	progression	stress	experience	outcomes	lung	variables	signs	techniques	areas	diseases	comorbidities	methods	proteins	infections	bone resorption	illness	sites	agents	functions	respiratory failure	bisphosphonates	medications	inflammatory mediators	lung disease	metabolic syndrome	skeletal muscle	systemic inflammation	chronic inflammation	childhood	clinical features	processes	modalities	therapies	malignancies	coagulation	inflammatory diseases	approaches	disease	states	diseases	organs	chronic diseases	pathways	risk factors	clinical parameters	patient characteristics	vasculitis	abuse	neurological disorders	complication	conditions	environmental factors	respiratory diseases	chronic lung disease	overload	hemostasis	several factors	pathological conditions	organs	fluids	many factors	tobacco smoke	pulmonary diseases	neurodegenerative diseases	parameters	allergic diseases	chronic conditions	multiple factors	clinical conditions	lung diseases	mechanisms	protein	expressions	disease states	soft tissues	Disorders	systemic effects	atherothrombosis	body fluids	insults	characteristics	treatments	Comorbidities	inflammatory factors	comorbidities	lethargy	cancers	respiratory problems	biological processes	bone diseases	etiologies	various cancers	host factors	chronic inflammatory conditions	bone-targeted agents	airway diseases	fluid overload	non-specific symptoms	Other variables	osteoclast function	systemic factors	allergic disorders	rare diseases	approaches	many diseases	tumours	various diseases	biological fluids	tumors	peripheral tissues	novel approaches	precipitants	Environmental factors	tissues	painful conditions	different tumors	severe diseases	complex disease	secondary effects	underlying conditions	various malignancies	Other risk factors	clinical outcomes	obstructive lung diseases	long-term side effects	specific diseases	Bone-targeted agents	antiresorptive agents	co-morbid conditions	metabolic bone diseases	objective signs	obstructive lung disease	physiological responses	underlying diseases	clinical details	multifactorial diseases	emotional factors	epidemiologic risk factors	patient-centered outcomes	side effects	smoking-related diseases	biofluids	chronic health conditions	life style factors	serious diseases	Post-operative complications	anti-resorptive agents	chronic lung disease	different variables	excessive bone resorption	obesity-related diseases	Clinical conditions	bone resorption inhibitors	cellular responses	chronic inflammatory lung diseases	chronic respiratory diseases	degenerative diseases	hormone-dependent cancers	interventricular delay	potent bone-targeted agents	pulmonary disorders	serious disorders	solid tumour	Negative emotional states	adverse health effects	chronic respiratory illnesses	common source	disease-associated factors	experimental interventions	frequent adverse events	hospitalization data	intravenous contrast	non-cardiovascular co-morbidities	pathologies	afflictions	anti-resorptive drugs	blood inflammatory markers	certain cancer types	certain disease	chronic medical conditions	co-existing diseases	concomitant illnesses	diagnostic specimens	disease areas	diverse disorders	experiential phenomena	explanatory variables	foreign materials	inflammatory cytokines	inflammatory respiratory diseases	injectable biological fluids	irreversible events	irreversible results	lung conditions	medication	non-atherosclerotic etiology	osteoclast-targeting agents	pacemaker function	perioperative side effects	prevalent pulmonary diseases	pulmonary illness	relevant processes	self-perceived aspects	significant co morbidity	surrogate tissue	systemic bone-targeted agents	AO-related areas	Complex diseases	IgE-dependent diseases	Mechanical parameters	Some perceived barriers	Th2-related disease	Traditional drugs	address lifestyle factors	adequate means	age-related problems	airway inflammations	biological state	bone osteolysis	bone-related disorders	bronchial etiologies	chronic airway inflammatory diseases	chronic lung conditions	chronic obstructive lung diseases	chronic pulmonary disorders	comobidities	current additional allergic symptoms	different carcinoma localizations	different target organs	driven diseases	energy intake disease conditions	high comorbidity	high device-related complications	human airways diseases	identical stimuli	inflammatory lung diseases	influence processes	insulin-sensitive organs	long-term pulmonary impairments	major diseases	major inflammatory diseases	major medical illnesses	many consequences	mental states	migraine trigger	multi-factorial disorder	multiple significant adverse reactions	negative factors	non-smokers.18 Other lifestyle factors	normal physiologic processes	others diseases	pathologic tissue destruction	physical barriers	possessed risk factors	primary sites	prior non-malignant lung disease	proper cell lineages	relevant entity	respiratory system events	shock-like symptoms	skeletal muscle injuries	smoking hazards	specific physical stimuli	systematic status	typical clinical features	various health-related issues	various respiratory health problems	well-known adolescent public health problems	young adult mice	“ anti-resorptive ” agents
treatment	cases	disease	risk	cancer	inflammation	symptoms	breast cancer	hypertension	function	infection	heart failure	pain	therapy	asthma	factors	patient	risk factors	blood	complications	cardiovascular disease	tumors	effects	stimulation	conditions	lung cancer	progression	parameters	factor	stress	experience	heart	outcomes	events	lung	variables	techniques	drugs	areas	diseases	tissues	cancers	others	findings	comorbidities	lymphoma	methods	molecules	proteins	infections	disorders	bone resorption	illness	proinflammatory cytokines	cardiovascular events	sites	agents	endothelial dysfunction	functions	syncope	risks	side effects	adverse events	respiratory failure	bisphosphonates	medications	growth factors	problems	inflammatory mediators	cardiovascular diseases	cardiovascular risk factors	headache disorders	lung disease	metabolic syndrome	skeletal muscle	surgeons	factors	systemic inflammation	chronic inflammation	consequences	childhood	clinical features	processes	modalities	Factors	respiratory symptoms	article	therapies	metabolic syndrome	causes	autoimmune diseases	target genes	malignancies	Mediators	agonists	coagulation	inflammatory diseases	indicators	adult patients	approaches	disease	states	comorbidity	psychiatric disorders	diseases	organs	chronic diseases	pathways	thrombosis	Risk factors	habits	hormones	risk factors	clinical parameters	patient characteristics	vasculitis	abuse	neurological disorders	complication	complaints	conditions	environmental factors	respiratory diseases	comorbid conditions	chronic lung disease	overload	myocardial injury	hemodynamic instability	cancers	hemostasis	consequences	several factors	vascular risk factors	inflammatory conditions	pathological conditions	co-morbidities	organs	adverse outcomes	adulthood	risk factor	autoimmune disease	fluids	serious complications	many factors	tobacco smoke	pulmonary diseases	traditional risk factors	cause	neurodegenerative diseases	surgical interventions	symptoms	parameters	allergic diseases	chronic conditions	multiple factors	important factors	chronic inflammatory diseases	clinical conditions	lung diseases	peripheral neuropathy	outcome measures	respiratory complications	mechanisms	secondary causes	vascular diseases	clinical factors	protein	chemotherapeutic agents	expressions	somatic symptoms	disease states	human diseases	mental disorders	neoplasm	neuropsychiatric disorders	soft tissues	mood disorders	subclinical atherosclerosis	Disorders	etiologies	metabolic diseases	health outcomes	medical conditions	severe outcomes	important risk factors	systemic effects	lung transplant	severe complications	volume overload	atherothrombosis	systemic diseases	body fluids	autoimmune disorders	insults	characteristics	treatments	Comorbidities	inflammatory factors	comorbidities	immobility	cancers	hypercoagulability	complications	demographic factors	structural heart disease	different diseases	respiratory problems	multiple comorbidities	biological processes	bone diseases	mechanisms	malignancy	cancer types	cardiac risk factors	etiologies	various cancers	affective disorders	host factors	constitutional symptoms	microvascular disease	cardiovascular disorders	chronic inflammatory conditions	comorbidity	bone-targeted agents	airway diseases	potential complications	cardiac conditions	fluid overload	several diseases	pathologic conditions	specific symptoms	inotropes	non-specific symptoms	traditional cardiovascular risk factors	Other variables	chronic diseases	lifestyle habits	neurological conditions	risk groups	neuropsychiatric symptoms	neurotransmitters	osteoclast function	psychological problems	systemic factors	allergic disorders	barotrauma	major adverse events	rare diseases	immune dysregulation	nonspecific symptoms	approaches	ischemic conditions	many diseases	tumours	various diseases	agents	biological fluids	cardiovascular symptoms	tumors	another disorder	multiple risk factors	peripheral tissues	Diseases	additional risk factors	invasive mechanical ventilation	metabolic dysfunction	novel approaches	precipitants	Environmental factors	tissues	carcinogens	painful conditions	regulatory proteins	additional factors	causative factors	different tumors	possible confounders	cardiometabolic risk factors	left heart disease	severe diseases	autonomic regulation	complex disease	secondary effects	threats	underlying conditions	various malignancies	Other risk factors	illnesses	significant comorbidities	atherosclerotic risk factors	clinical outcomes	obstructive lung diseases	certain situations	long-term side effects	specific diseases	Bone-targeted agents	different stimuli	gastrointestinal disturbances	intracranial lesions	common comorbidities	exogenous sources	important clinical outcomes	sensory symptoms	specific domains	antiresorptive agents	co-morbid conditions	metabolic bone diseases	objective signs	obstructive lung disease	physiological responses	related conditions	secreted proteins	underlying diseases	vascular risk factors	All factors	cardiac manifestations	chronic inflammatory condition	chronic medical conditions	clinical details	comorbid condition	increased sympathetic activity	multifactorial diseases	peripheral neuropathies	proinflammatory conditions	various complications	acute respiratory events	certain risk factors	emotional factors	epidemiologic risk factors	neuropsychiatric manifestations	non-communicable diseases	patient-centered outcomes	respiratory symptoms	secondary causes	side effects	significant symptoms	smoking-related diseases	All variables	Other complications	anastomotic leak	antecedent events	biofluids	chronic health conditions	co-morbidities	life style factors	noncommunicable diseases	serious diseases	various symptoms	vascular conditions	Post-operative complications	ailments	anti-resorptive agents	categorical predictors	chronic lung disease	different variables	excessive bone resorption	medical comorbidity	obesity-related diseases	respiratory manifestations	significant complications	unspecific symptoms	Clinical conditions	Outcomes	bone resorption inhibitors	cellular responses	chronic comorbidities	chronic inflammatory lung diseases	high-risk subgroups	lifestyle-related diseases	neuropsychiatric factors	acute conditions	benign entities	cardiovascular co-morbidities	chronic respiratory diseases	co-morbid diseases	degenerative diseases	hormone-dependent cancers	immunocompromised hosts	insult	interventricular delay	lifestyle exposures	many tumours	possible problems	post-operative complications	potent bone-targeted agents	pulmonary disorders	secondary repolarization abnormalities	serious disorders	solid tumour	substantial risk	systemic circulation	tumor types	Negative emotional states	adverse health effects	chronic respiratory illnesses	common source	disease-associated factors	experimental interventions	external signals	frequent adverse events	intravenous contrast	major outcome	non-cardiovascular co-morbidities	non-specific constitutional symptoms	pathologies	systemic pathologies	COPD-related diseases	afflictions	anti-resorptive drugs	biologic substances	blood inflammatory markers	certain cancer types	certain disease	chronic medical conditions	chronic medical problems	co-existing diseases	common cardiovascular conditions	concomitant illnesses	constitutional symptoms	diagnostic specimens	disease areas	diverse disorders	experiential phenomena	explanatory variables	foreign materials	gastric complications	heterogeneous entities	important symptom	incident cardiovascular disease events	inflammatory cytokines	inflammatory respiratory diseases	injectable biological fluids	irreversible events	irreversible results	lung conditions	medical complications	medical diseases	medication	non-atherosclerotic etiology	osteoclast-targeting agents	pacemaker function	pathological settings	perioperative side effects	postprocedural complications	pressure overload states	prevalent pulmonary diseases	pulmonary illness	relevant processes	self-perceived aspects	several cardiovascular conditions	significant co morbidity	special diseases	surrogate tissue	systemic bone-targeted agents	vasopressin production	AO-related areas	Age-related vascular factors	Complex diseases	IgE-dependent diseases	Mechanical parameters	No major acute complications	Pre-operative risk factors	Serious side effects	Short-term risks	Significant past medical history	Some perceived barriers	Th2-related disease	The standard risk factors	Traditional drugs	acute event	acute thromboembolic events	additional cardiovascular co-morbidities	address lifestyle factors	adequate means	administrative characteristics	age-related comorbidities	age-related problems	airway inflammations	arrhythmic risk factors	asymptomatic chronic diseases	asymptomatic disorder	atherosclerosis risk factors	biochemistry factors	biological state	bone osteolysis	bone-related disorders	bronchial etiologies	cardiovascular diseases	cardiovascular risk comorbidities	certain common symptoms	chronic airway inflammatory diseases	chronic autoimmune diseases	chronic lung conditions	chronic medical condition	chronic obstructive lung diseases	chronic pulmonary disorders	classic cardiovascular risk factors	classic prodromal features	clinical outcomes	co-existing systemic disease	common comorbid conditions	community-acquired infections	comobidities	comparable samples	complex disorders	concomitant inflammatory diseases	current additional allergic symptoms	current medical conditions	definitive outcomes	different carcinoma localizations	different clinical setting	different environmental exposures	different target organs	diffuse ischemia	driven diseases	energy intake disease conditions	event risks	exhibits several COPD-associated co-morbidities	experience side effects	frequent co-morbidities,43	gastrointestinal complications	generalized vascular pathology	high comorbidity	high device-related complications	high oxidative capacity	high-risk features	higher-risk features	human airways diseases	ictal phenomena	important co-morbidites	important comorbidities	inflammatory lung diseases	influence processes	infrequent endpoints	insulin-sensitive organs	irritative sensory features	long term support complications	long-term pulmonary impairments	longer-term complications	low-incidence complications	major atherosclerotic macrovascular events	major diseases	major inflammatory diseases	major medical illnesses	many connective tissue diseases	many consequences	many immune-related diseases	mental states	microtubule-targeted drugs	migraine trigger	mild-to-severe gastrointestinal side effects	modifiable cardiovascular risk factors	multi-factorial disorder	multiple significant adverse reactions	negative factors	non-smokers.18 Other lifestyle factors	nonemotional characteristics	normal disease tissues	normal physiologic processes	obesity-related condition	organ toxicities	osteolytic bone conditions	others diseases	palliative care symptoms	pathologic tissue destruction	permanent serious disease	physical barriers	possessed risk factors	potent biochemical mediators	pre-existing chronic diseases	primary sites	prior non-malignant lung disease	progenitor states	proper cell lineages	relevant entity	respiratory system events	score,43 comorbidities	secondary dyslipidemias	significant behavioral health concerns	significant inflammatory component	similar circumstances	skeletal muscle injuries	smoking hazards	soft tissue involvement	special medications	specific physical stimuli	strong vascular risk factors	systematic status	thrombotic event	tissue symptoms	tongue symptoms	traditional cardiovascular risk parameters	treatment toxicities	underlying clinical condition	unrecognised.1 Characteristics	usual cardiovascular risk factors	various cancer entities	various health-related issues	various respiratory health problems	well-known adolescent public health problems	well-known ischemic risk factors	well-known pathologies	young adult mice	’ prenatal history	“ anti-resorptive ” agents
opioids	morphine	acute treatments	receptor ligands	common analgesic drugs	opioid analgesics	strong opioid analgesics
therapy	blood	stimulation	methods	agents	functions	modalities	therapies	approaches	disease	states	pathways	vasculitis	abuse	neurological disorders	complication	platelet	environmental factors	fluids	multiple factors	mechanisms	soft tissues	body fluids	cancers	bone-targeted agents	osteoclast function	approaches	biological fluids	Other risk factors	Molecules	Bone-targeted agents	antiresorptive agents	epidemiologic risk factors	biofluids	life style factors	anti-resorptive agents	potent bone-targeted agents	diagnostic specimens	foreign materials	injectable biological fluids	non-atherosclerotic etiology	pacemaker function	surrogate tissue	biological state	key mitogens	multiple significant adverse reactions	non-smokers.18 Other lifestyle factors	proper cell lineages	“ anti-resorptive ” agents
treatment	disease	cancer	inflammation	symptoms	breast cancer	function	therapy	asthma	factors	patient	risk factors	blood	complications	stimulation	conditions	lung cancer	progression	stress	experience	outcomes	lung	variables	techniques	areas	diseases	comorbidities	methods	proteins	infections	bone resorption	illness	bleeding	sites	agents	functions	risks	side effects	respiratory failure	bisphosphonates	medications	inflammatory mediators	lung disease	metabolic syndrome	skeletal muscle	systemic inflammation	chronic inflammation	childhood	clinical features	processes	modalities	therapies	malignancies	coagulation	inflammatory diseases	approaches	disease	states	diseases	organs	chronic diseases	pathways	risk factors	clinical parameters	patient characteristics	vasculitis	abuse	neurological disorders	complication	complaints	conditions	environmental factors	respiratory diseases	chronic lung disease	overload	hemostasis	several factors	pathological conditions	organs	fluids	many factors	tobacco smoke	pulmonary diseases	neurodegenerative diseases	surgical interventions	parameters	allergic diseases	chronic conditions	multiple factors	clinical conditions	lung diseases	mechanisms	protein	expressions	disease states	soft tissues	Disorders	systemic effects	lung transplant	atherothrombosis	body fluids	insults	characteristics	treatments	Comorbidities	inflammatory factors	comorbidities	cancers	hypercoagulability	complications	respiratory problems	biological processes	bone diseases	etiologies	various cancers	host factors	chronic inflammatory conditions	bone-targeted agents	airway diseases	potential complications	fluid overload	non-specific symptoms	Other variables	osteoclast function	systemic factors	allergic disorders	rare diseases	nonspecific symptoms	approaches	many diseases	tumours	various diseases	biological fluids	cardiovascular symptoms	tumors	peripheral tissues	novel approaches	precipitants	Environmental factors	tissues	painful conditions	different tumors	severe diseases	complex disease	secondary effects	underlying conditions	various malignancies	Other risk factors	clinical outcomes	obstructive lung diseases	long-term side effects	specific diseases	Bone-targeted agents	antiresorptive agents	co-morbid conditions	metabolic bone diseases	objective signs	obstructive lung disease	physiological responses	underlying diseases	clinical details	multifactorial diseases	various complications	emotional factors	epidemiologic risk factors	patient-centered outcomes	related complications	side effects	smoking-related diseases	Other complications	antecedent events	biofluids	chronic health conditions	life style factors	serious diseases	Post-operative complications	anti-resorptive agents	chronic lung disease	different variables	excessive bone resorption	medical comorbidity	obesity-related diseases	significant complications	Clinical conditions	bone resorption inhibitors	cellular responses	chronic inflammatory lung diseases	chronic respiratory diseases	degenerative diseases	hormone-dependent cancers	interventricular delay	post-operative complications	potent bone-targeted agents	pulmonary disorders	serious disorders	solid tumour	substantial risk	Negative emotional states	adverse health effects	chronic respiratory illnesses	common source	disease-associated factors	experimental interventions	frequent adverse events	intravenous contrast	non-cardiovascular co-morbidities	pathologies	afflictions	anti-resorptive drugs	blood inflammatory markers	certain cancer types	certain disease	chronic medical conditions	co-existing diseases	concomitant illnesses	diagnostic specimens	disease areas	diverse disorders	experiential phenomena	explanatory variables	foreign materials	gastric complications	general problems	important symptom	inflammatory cytokines	inflammatory respiratory diseases	injectable biological fluids	irreversible events	irreversible results	lung conditions	medication	non-atherosclerotic etiology	osteoclast-targeting agents	pacemaker function	perioperative side effects	postprocedural complications	prevalent pulmonary diseases	pulmonary illness	relevant processes	self-perceived aspects	significant co morbidity	surrogate tissue	systemic bone-targeted agents	AO-related areas	Complex diseases	IgE-dependent diseases	Mechanical parameters	Short-term risks	Some perceived barriers	Th2-related disease	Traditional drugs	address lifestyle factors	adequate means	age-related problems	airway inflammations	biological state	bone osteolysis	bone-related disorders	bronchial etiologies	chronic airway inflammatory diseases	chronic lung conditions	chronic obstructive lung diseases	chronic pulmonary disorders	comobidities	current additional allergic symptoms	different carcinoma localizations	different target organs	driven diseases	energy intake disease conditions	gastrointestinal complications	high comorbidity	high device-related complications	human airways diseases	inflammatory lung diseases	influence processes	insulin-sensitive organs	long term support complications	long-term pulmonary impairments	major diseases	major inflammatory diseases	major medical illnesses	many complications	many consequences	mental states	migraine trigger	multi-factorial disorder	multiple significant adverse reactions	negative factors	non-smokers.18 Other lifestyle factors	normal physiologic processes	others diseases	pathologic tissue destruction	physical barriers	possessed risk factors	primary sites	prior non-malignant lung disease	proper cell lineages	relevant entity	respiratory system events	skeletal muscle injuries	smoking hazards	specific physical stimuli	systematic status	various health-related issues	various respiratory health problems	well-known adolescent public health problems	young adult mice	“ anti-resorptive ” agents
treatment	cases	disease	risk	cancer	inflammation	symptoms	breast cancer	function	infection	heart failure	pain	therapy	asthma	factors	patient	risk factors	blood	complications	cardiovascular disease	tumors	stimulation	conditions	lung cancer	progression	parameters	factor	stress	experience	heart	outcomes	events	lung	variables	techniques	drugs	areas	diseases	findings	comorbidities	lymphoma	methods	proteins	infections	bone resorption	illness	cardiovascular events	sites	agents	endothelial dysfunction	functions	syncope	risks	side effects	adverse events	respiratory failure	bisphosphonates	medications	inflammatory mediators	cardiovascular diseases	cardiovascular risk factors	headache disorders	lung disease	metabolic syndrome	skeletal muscle	surgeons	factors	systemic inflammation	chronic inflammation	consequences	childhood	clinical features	processes	modalities	Factors	therapies	metabolic syndrome	causes	autoimmune diseases	malignancies	coagulation	inflammatory diseases	adult patients	approaches	disease	states	diseases	organs	chronic diseases	pathways	Risk factors	habits	risk factors	clinical parameters	patient characteristics	vasculitis	abuse	neurological disorders	complication	cocaine	complaints	conditions	environmental factors	respiratory diseases	comorbid conditions	chronic lung disease	overload	myocardial injury	hemostasis	consequences	several factors	vascular risk factors	pathological conditions	co-morbidities	organs	adulthood	risk factor	autoimmune disease	fluids	serious complications	many factors	tobacco smoke	pulmonary diseases	traditional risk factors	cause	neurodegenerative diseases	surgical interventions	symptoms	parameters	allergic diseases	chronic conditions	multiple factors	chronic inflammatory diseases	clinical conditions	lung diseases	peripheral neuropathy	outcome measures	respiratory complications	mechanisms	vascular diseases	clinical factors	protein	chemotherapeutic agents	expressions	somatic symptoms	disease states	human diseases	soft tissues	subclinical atherosclerosis	Disorders	etiologies	metabolic diseases	health outcomes	medical conditions	severe outcomes	important risk factors	systemic effects	lung transplant	volume overload	atherothrombosis	systemic diseases	body fluids	autoimmune disorders	insults	characteristics	treatments	Comorbidities	inflammatory factors	comorbidities	immobility	cancers	hypercoagulability	complications	demographic factors	structural heart disease	different diseases	respiratory problems	multiple comorbidities	biological processes	bone diseases	mechanisms	malignancy	cardiac risk factors	etiologies	various cancers	host factors	constitutional symptoms	microvascular disease	cardiovascular disorders	chronic inflammatory conditions	comorbidity	bone-targeted agents	airway diseases	potential complications	cardiac conditions	fluid overload	several diseases	pathologic conditions	non-specific symptoms	Other variables	chronic diseases	lifestyle habits	neurological conditions	risk groups	osteoclast function	systemic factors	allergic disorders	major adverse events	rare diseases	immune dysregulation	nonspecific symptoms	approaches	ischemic conditions	many diseases	tumours	various diseases	agents	biological fluids	cardiovascular symptoms	tumors	another disorder	multiple risk factors	peripheral tissues	additional risk factors	metabolic dysfunction	novel approaches	precipitants	Environmental factors	tissues	carcinogens	painful conditions	additional factors	causative factors	different tumors	possible confounders	left heart disease	severe diseases	autonomic regulation	complex disease	secondary effects	threats	underlying conditions	various malignancies	Other risk factors	illnesses	significant comorbidities	atherosclerotic risk factors	clinical outcomes	obstructive lung diseases	certain situations	long-term side effects	specific diseases	Bone-targeted agents	common comorbidities	exogenous sources	sensory symptoms	antiresorptive agents	co-morbid conditions	metabolic bone diseases	objective signs	obstructive lung disease	physiological responses	related conditions	underlying diseases	vascular risk factors	All factors	cardiac manifestations	chronic inflammatory condition	chronic medical conditions	clinical details	comorbid condition	increased sympathetic activity	multifactorial diseases	peripheral neuropathies	proinflammatory conditions	various complications	acute respiratory events	certain risk factors	emotional factors	epidemiologic risk factors	neuropsychiatric manifestations	non-communicable diseases	patient-centered outcomes	side effects	significant symptoms	smoking-related diseases	All variables	Other complications	antecedent events	biofluids	chronic health conditions	co-morbidities	life style factors	noncommunicable diseases	serious diseases	Post-operative complications	ailments	anti-resorptive agents	categorical predictors	chronic lung disease	different variables	excessive bone resorption	medical comorbidity	obesity-related diseases	significant complications	Clinical conditions	Outcomes	bone resorption inhibitors	cellular responses	chronic comorbidities	chronic inflammatory lung diseases	high-risk subgroups	lifestyle-related diseases	acute conditions	benign entities	chronic respiratory diseases	co-morbid diseases	degenerative diseases	hormone-dependent cancers	immunocompromised hosts	insult	interventricular delay	lifestyle exposures	possible problems	post-operative complications	potent bone-targeted agents	pulmonary disorders	secondary repolarization abnormalities	serious disorders	solid tumour	substantial risk	systemic circulation	Negative emotional states	adverse health effects	chronic respiratory illnesses	common source	disease-associated factors	experimental interventions	external signals	frequent adverse events	intravenous contrast	non-cardiovascular co-morbidities	non-specific constitutional symptoms	pathologies	systemic pathologies	COPD-related diseases	afflictions	anti-resorptive drugs	blood inflammatory markers	certain cancer types	certain disease	chronic medical conditions	co-existing diseases	concomitant illnesses	constitutional symptoms	diagnostic specimens	disease areas	diverse disorders	experiential phenomena	explanatory variables	foreign materials	gastric complications	heterogeneous entities	illicit drugs	important symptom	incident cardiovascular disease events	inflammatory cytokines	inflammatory respiratory diseases	injectable biological fluids	irreversible events	irreversible results	lung conditions	medical complications	medication	non-atherosclerotic etiology	osteoclast-targeting agents	pacemaker function	pathological settings	perioperative side effects	postprocedural complications	prevalent pulmonary diseases	pulmonary illness	relevant processes	self-perceived aspects	several cardiovascular conditions	significant co morbidity	special diseases	surrogate tissue	systemic bone-targeted agents	vasopressin production	AO-related areas	Complex diseases	IgE-dependent diseases	Mechanical parameters	No major acute complications	Pre-operative risk factors	Short-term risks	Some perceived barriers	Th2-related disease	The standard risk factors	Traditional drugs	acute event	acute thromboembolic events	additional cardiovascular co-morbidities	address lifestyle factors	adequate means	administrative characteristics	age-related comorbidities	age-related problems	airway inflammations	arrhythmic risk factors	asymptomatic chronic diseases	biological state	bone osteolysis	bone-related disorders	bronchial etiologies	cardiovascular diseases	cardiovascular risk comorbidities	certain common symptoms	chronic airway inflammatory diseases	chronic autoimmune diseases	chronic lung conditions	chronic medical condition	chronic obstructive lung diseases	chronic pulmonary disorders	classic cardiovascular risk factors	co-existing systemic disease	common comorbid conditions	community-acquired infections	comobidities	comparable samples	complex disorders	concomitant inflammatory diseases	current additional allergic symptoms	current medical conditions	different carcinoma localizations	different clinical setting	different environmental exposures	different target organs	diffuse ischemia	driven diseases	energy intake disease conditions	event risks	exhibits several COPD-associated co-morbidities	experience side effects	frequent co-morbidities,43	gastrointestinal complications	generalized vascular pathology	high comorbidity	high device-related complications	high oxidative capacity	high-risk features	higher-risk features	human airways diseases	ictal phenomena	important co-morbidites	important comorbidities	inflammatory lung diseases	influence processes	insulin-sensitive organs	irritative sensory features	long term support complications	long-term pulmonary impairments	longer-term complications	major atherosclerotic macrovascular events	major diseases	major inflammatory diseases	major medical illnesses	many connective tissue diseases	many consequences	many immune-related diseases	mental states	microtubule-targeted drugs	migraine trigger	multi-factorial disorder	multiple significant adverse reactions	negative factors	non-smokers.18 Other lifestyle factors	nonemotional characteristics	noradrenaline re-uptake	normal physiologic processes	organ toxicities	osteolytic bone conditions	others diseases	palliative care symptoms	pathologic tissue destruction	permanent serious disease	physical barriers	possessed risk factors	pre-existing chronic diseases	primary sites	prior non-malignant lung disease	progenitor states	proper cell lineages	relevant entity	respiratory system events	score,43 comorbidities	secondary dyslipidemias	significant inflammatory component	similar circumstances	skeletal muscle injuries	smoking hazards	soft tissue involvement	specific physical stimuli	strong vascular risk factors	systematic status	tissue symptoms	tongue symptoms	unrecognised.1 Characteristics	usual cardiovascular risk factors	various health-related issues	various respiratory health problems	well-known adolescent public health problems	well-known pathologies	young adult mice	’ prenatal history	“ anti-resorptive ” agents
treatment	disease	cancer	inflammation	breast cancer	function	therapy	asthma	factors	patient	risk factors	blood	complications	stimulation	conditions	lung cancer	progression	experience	outcomes	lung	variables	techniques	areas	diseases	comorbidities	fracture	methods	proteins	bone resorption	illness	sites	agents	functions	respiratory failure	bisphosphonates	medications	inflammatory mediators	lung disease	metabolic syndrome	skeletal muscle	systemic inflammation	chronic inflammation	childhood	clinical features	processes	modalities	therapies	malignancies	coagulation	inflammatory diseases	instability	approaches	disease	states	diseases	organs	chronic diseases	pathways	risk factors	patient characteristics	vasculitis	abuse	neurological disorders	complication	conditions	environmental factors	respiratory diseases	chronic lung disease	overload	hemostasis	several factors	pathological conditions	organs	fluids	tobacco smoke	pulmonary diseases	neurodegenerative diseases	parameters	allergic diseases	chronic conditions	multiple factors	clinical conditions	lung diseases	mechanisms	protein	expressions	disease states	soft tissues	Disorders	systemic effects	atherothrombosis	body fluids	insults	treatments	Comorbidities	inflammatory factors	comorbidities	cancers	respiratory problems	biological processes	bone diseases	various cancers	host factors	bone-targeted agents	airway diseases	fluid overload	non-specific symptoms	Other variables	osteoclast function	systemic factors	allergic disorders	rare diseases	approaches	tumours	various diseases	biological fluids	tumors	peripheral tissues	novel approaches	Environmental factors	tissues	painful conditions	different tumors	severe diseases	complex disease	secondary effects	underlying conditions	various malignancies	Other risk factors	obstructive lung diseases	long-term side effects	specific diseases	Bone-targeted agents	antiresorptive agents	co-morbid conditions	metabolic bone diseases	objective signs	obstructive lung disease	physiological responses	underlying diseases	clinical details	multifactorial diseases	emotional factors	epidemiologic risk factors	side effects	smoking-related diseases	biofluids	chronic health conditions	life style factors	serious diseases	Post-operative complications	anti-resorptive agents	chronic lung disease	different variables	excessive bone resorption	obesity-related diseases	Clinical conditions	bone resorption inhibitors	cellular responses	chronic inflammatory lung diseases	chronic respiratory diseases	degenerative diseases	hormone-dependent cancers	interventricular delay	potent bone-targeted agents	pulmonary disorders	serious disorders	solid tumour	Negative emotional states	adverse health effects	chronic respiratory illnesses	disease-associated factors	experimental interventions	intravenous contrast	non-cardiovascular co-morbidities	pathologies	afflictions	anti-resorptive drugs	blood inflammatory markers	certain cancer types	certain disease	chronic medical conditions	co-existing diseases	concomitant illnesses	diagnostic specimens	disease areas	diverse disorders	foreign materials	inflammatory cytokines	inflammatory respiratory diseases	injectable biological fluids	irreversible events	irreversible results	lung conditions	medication	non-atherosclerotic etiology	osteoclast-targeting agents	pacemaker function	perioperative side effects	prevalent pulmonary diseases	pulmonary illness	relevant processes	significant co morbidity	surrogate tissue	systemic bone-targeted agents	AO-related areas	Complex diseases	IgE-dependent diseases	Some perceived barriers	Th2-related disease	Traditional drugs	adequate means	age-related problems	airway inflammations	biological state	bone-related disorders	bronchial etiologies	chronic airway inflammatory diseases	chronic lung conditions	chronic obstructive lung diseases	chronic pulmonary disorders	comobidities	current additional allergic symptoms	dichotomous later-life events	different carcinoma localizations	different target organs	driven diseases	energy intake disease conditions	high comorbidity	human airways diseases	inflammatory lung diseases	influence processes	insulin-sensitive organs	long-term pulmonary impairments	major diseases	major inflammatory diseases	major medical illnesses	many consequences	multi-factorial disorder	multiple significant adverse reactions	negative factors	non-smokers.18 Other lifestyle factors	normal physiologic processes	others diseases	pathologic tissue destruction	physical barriers	possessed risk factors	primary sites	prior non-malignant lung disease	proper cell lineages	relevant entity	respiratory system events	skeletal muscle injuries	smoking hazards	systematic status	various health-related issues	various respiratory health problems	well-known adolescent public health problems	young adult mice	“ anti-resorptive ” agents
disease	cancer	inflammation	function	therapy	asthma	factors	patient	risk factors	blood	complications	stimulation	conditions	lung cancer	progression	experience	outcomes	lung	techniques	diseases	comorbidities	methods	proteins	bone resorption	illness	sites	agents	functions	respiratory failure	bisphosphonates	inflammatory mediators	lung disease	metabolic syndrome	skeletal muscle	chronic inflammation	childhood	clinical features	processes	modalities	therapies	malignancies	coagulation	inflammatory diseases	approaches	disease	states	diseases	organs	chronic diseases	pathways	risk factors	vasculitis	abuse	neurological disorders	complication	conditions	environmental factors	respiratory diseases	chronic lung disease	hemostasis	pathological conditions	organs	fluids	tobacco smoke	pulmonary diseases	neurodegenerative diseases	parameters	allergic diseases	chronic conditions	multiple factors	lung diseases	mechanisms	protein	disease states	soft tissues	Disorders	systemic effects	atherothrombosis	body fluids	Comorbidities	inflammatory factors	comorbidities	cancers	respiratory problems	biological processes	bone diseases	various cancers	host factors	bone-targeted agents	airway diseases	fluid overload	non-specific symptoms	Other variables	osteoclast function	systemic factors	allergic disorders	rare diseases	approaches	tumours	biological fluids	peripheral tissues	tissues	painful conditions	different tumors	severe diseases	secondary effects	underlying conditions	various malignancies	Other risk factors	obstructive lung diseases	long-term side effects	specific diseases	Bone-targeted agents	cachexia	antiresorptive agents	co-morbid conditions	metabolic bone diseases	objective signs	obstructive lung disease	physiological responses	underlying diseases	multifactorial diseases	emotional factors	epidemiologic risk factors	side effects	smoking-related diseases	biofluids	chronic health conditions	life style factors	serious diseases	Post-operative complications	anti-resorptive agents	chronic lung disease	different variables	excessive bone resorption	obesity-related diseases	Clinical conditions	bone resorption inhibitors	cellular responses	chronic inflammatory lung diseases	chronic respiratory diseases	degenerative diseases	interventricular delay	potent bone-targeted agents	pulmonary disorders	serious disorders	solid tumour	Negative emotional states	adverse health effects	chronic respiratory illnesses	experimental interventions	non-cardiovascular co-morbidities	pathologies	afflictions	anti-resorptive drugs	blood inflammatory markers	certain cancer types	certain disease	chronic medical conditions	co-existing diseases	concomitant illnesses	diagnostic specimens	disease areas	diverse disorders	foreign materials	inflammatory cytokines	inflammatory respiratory diseases	injectable biological fluids	irreversible events	irreversible results	lung conditions	medication	non-atherosclerotic etiology	osteoclast-targeting agents	pacemaker function	prevalent pulmonary diseases	pulmonary illness	relevant processes	significant co morbidity	surrogate tissue	systemic bone-targeted agents	AO-related areas	Complex diseases	IgE-dependent diseases	Th2-related disease	Traditional drugs	adequate means	age-related problems	airway inflammations	biological state	bone-related disorders	bronchial etiologies	chronic airway inflammatory diseases	chronic lung conditions	chronic obstructive lung diseases	chronic pulmonary disorders	comobidities	current additional allergic symptoms	different target organs	driven diseases	energy intake disease conditions	high comorbidity	human airways diseases	inflammatory lung diseases	influence processes	insulin-sensitive organs	long-term pulmonary impairments	major diseases	major inflammatory diseases	major medical illnesses	many consequences	multi-factorial disorder	multiple significant adverse reactions	negative factors	non-smokers.18 Other lifestyle factors	normal physiologic processes	others diseases	pathologic tissue destruction	physical barriers	possessed risk factors	primary sites	prior non-malignant lung disease	proper cell lineages	relevant entity	respiratory system events	skeletal muscle injuries	smoking hazards	systematic status	various health-related issues	various respiratory health problems	well-known adolescent public health problems	young adult mice	“ anti-resorptive ” agents

treatment	cases	disease	risk	cancer	inflammation	symptoms	breast cancer	function	infection	heart failure	pain	therapy	asthma	factors	patient	risk factors	blood	complications	cardiovascular disease	tumors	stimulation	conditions	lung cancer	progression	parameters	factor	stress	experience	epilepsy	heart	outcomes	events	lung	variables	techniques	drugs	areas	diseases	tissues	cancers	others	findings	comorbidities	lymphoma	methods	molecules	proteins	infections	disorders	bone resorption	illness	proinflammatory cytokines	cardiovascular events	sites	agents	endothelial dysfunction	functions	syncope	risks	side effects	adverse events	respiratory failure	bisphosphonates	medications	growth factors	problems	inflammatory mediators	cardiovascular diseases	cardiovascular risk factors	headache disorders	lung disease	metabolic syndrome	skeletal muscle	surgeons	factors	systemic inflammation	chronic inflammation	consequences	childhood	clinical features	processes	modalities	Factors	therapies	metabolic syndrome	causes	autoimmune diseases	target genes	malignancies	Mediators	agonists	coagulation	inflammatory diseases	adult patients	approaches	disease	states	diseases	organs	chronic diseases	pathways	Risk factors	habits	hormones	risk factors	clinical parameters	patient characteristics	vasculitis	abuse	neurological disorders	complication	complaints	conditions	environmental factors	respiratory diseases	comorbid conditions	chronic lung disease	overload	myocardial injury	hemodynamic instability	cancers	hemostasis	consequences	several factors	vascular risk factors	pathological conditions	co-morbidities	organs	adulthood	risk factor	autoimmune disease	fluids	serious complications	many factors	tobacco smoke	pulmonary diseases	traditional risk factors	cause	neurodegenerative diseases	surgical interventions	symptoms	parameters	allergic diseases	chronic conditions	multiple factors	important factors	chronic inflammatory diseases	clinical conditions	lung diseases	peripheral neuropathy	outcome measures	respiratory complications	mechanisms	vascular diseases	clinical factors	protein	chemotherapeutic agents	expressions	somatic symptoms	disease states	human diseases	soft tissues	subclinical atherosclerosis	Disorders	etiologies	metabolic diseases	health outcomes	medical conditions	severe outcomes	important risk factors	systemic effects	lung transplant	severe complications	volume overload	atherothrombosis	systemic diseases	body fluids	autoimmune disorders	insults	characteristics	treatments	Comorbidities	inflammatory factors	comorbidities	immobility	cancers	hypercoagulability	complications	demographic factors	structural heart disease	different diseases	respiratory problems	multiple comorbidities	biological processes	bone diseases	mechanisms	malignancy	cancer types	cardiac risk factors	etiologies	various cancers	host factors	constitutional symptoms	microvascular disease	cardiovascular disorders	chronic inflammatory conditions	comorbidity	bone-targeted agents	airway diseases	potential complications	cardiac conditions	fluid overload	several diseases	pathologic conditions	inotropes	non-specific symptoms	Other variables	chronic diseases	lifestyle habits	neurological conditions	risk groups	neurotransmitters	osteoclast function	systemic factors	allergic disorders	barotrauma	major adverse events	rare diseases	immune dysregulation	nonspecific symptoms	approaches	ischemic conditions	many diseases	tumours	various diseases	agents	biological fluids	cardiovascular symptoms	tumors	another disorder	multiple risk factors	peripheral tissues	additional risk factors	invasive mechanical ventilation	metabolic dysfunction	novel approaches	precipitants	Environmental factors	tissues	carcinogens	painful conditions	regulatory proteins	additional factors	causative factors	different tumors	possible confounders	left heart disease	severe diseases	autonomic regulation	complex disease	secondary effects	threats	underlying conditions	various malignancies	Other risk factors	illnesses	significant comorbidities	atherosclerotic risk factors	clinical outcomes	obstructive lung diseases	certain situations	long-term side effects	specific diseases	Bone-targeted agents	different stimuli	intracranial lesions	common comorbidities	exogenous sources	sensory symptoms	antiresorptive agents	co-morbid conditions	metabolic bone diseases	objective signs	obstructive lung disease	physiological responses	related conditions	secreted proteins	underlying diseases	vascular risk factors	All factors	cardiac manifestations	chronic inflammatory condition	chronic medical conditions	clinical details	comorbid condition	increased sympathetic activity	multifactorial diseases	peripheral neuropathies	proinflammatory conditions	various complications	acute respiratory events	certain risk factors	emotional factors	epidemiologic risk factors	neuropsychiatric manifestations	non-communicable diseases	patient-centered outcomes	side effects	significant symptoms	smoking-related diseases	All variables	Other complications	anastomotic leak	antecedent events	biofluids	chronic health conditions	co-morbidities	different diagnosis	life style factors	noncommunicable diseases	serious diseases	vascular conditions	Post-operative complications	ailments	anti-resorptive agents	categorical predictors	chronic lung disease	different variables	excessive bone resorption	medical comorbidity	obesity-related diseases	significant complications	Clinical conditions	Outcomes	bone resorption inhibitors	cellular responses	chronic comorbidities	chronic inflammatory lung diseases	high-risk subgroups	lifestyle-related diseases	special problems	acute conditions	benign entities	chronic respiratory diseases	co-morbid diseases	degenerative diseases	hormone-dependent cancers	immunocompromised hosts	insult	interventricular delay	lifestyle exposures	many tumours	possible problems	post-operative complications	potent bone-targeted agents	pulmonary disorders	secondary repolarization abnormalities	serious disorders	solid tumour	substantial risk	systemic circulation	tumor types	Negative emotional states	adverse health effects	chronic respiratory illnesses	common source	disease-associated factors	experimental interventions	external signals	frequent adverse events	intravenous contrast	non-cardiovascular co-morbidities	non-specific constitutional symptoms	pathologies	systemic pathologies	COPD-related diseases	afflictions	anti-resorptive drugs	biologic substances	blood inflammatory markers	certain cancer types	certain disease	chronic medical conditions	co-existing diseases	concomitant illnesses	constitutional symptoms	diagnostic specimens	disease areas	diverse disorders	experiential phenomena	explanatory variables	foreign materials	gastric complications	heterogeneous entities	important symptom	incident cardiovascular disease events	inflammatory cytokines	inflammatory respiratory diseases	injectable biological fluids	irreversible events	irreversible results	lung conditions	medical complications	medication	neurological sequel	non-atherosclerotic etiology	osteoclast-targeting agents	pacemaker function	pathological settings	perioperative side effects	postprocedural complications	prevalent pulmonary diseases	pulmonary illness	relevant processes	self-perceived aspects	several cardiovascular conditions	significant co morbidity	special diseases	surrogate tissue	systemic bone-targeted agents	vasopressin production	AO-related areas	Complex diseases	IgE-dependent diseases	Mechanical parameters	No major acute complications	Pre-operative risk factors	Short-term risks	Some perceived barriers	Th2-related disease	The standard risk factors	Traditional drugs	acute event	acute thromboembolic events	additional cardiovascular co-morbidities	address lifestyle factors	adequate means	administrative characteristics	age-related comorbidities	age-related problems	airway inflammations	arrhythmic risk factors	asymptomatic chronic diseases	biochemistry factors	biological state	bone osteolysis	bone-related disorders	bronchial etiologies	cardiovascular diseases	cardiovascular risk comorbidities	certain common symptoms	chronic airway inflammatory diseases	chronic autoimmune diseases	chronic lung conditions	chronic medical condition	chronic obstructive lung diseases	chronic pulmonary disorders	classic cardiovascular risk factors	co-existing systemic disease	common comorbid conditions	community-acquired infections	comobidities	comparable samples	complex disorders	concomitant inflammatory diseases	current additional allergic symptoms	current medical conditions	different carcinoma localizations	different clinical setting	different environmental exposures	different target organs	diffuse ischemia	driven diseases	energy intake disease conditions	event risks	exhibits several COPD-associated co-morbidities	experience side effects	frequent co-morbidities,43	gastrointestinal complications	generalized vascular pathology	high comorbidity	high device-related complications	high oxidative capacity	high-risk features	higher-risk features	human airways diseases	ictal phenomena	important co-morbidites	important comorbidities	inflammatory lung diseases	influence processes	insulin-sensitive organs	irritative sensory features	long term support complications	long-term pulmonary impairments	longer-term complications	low-incidence complications	major atherosclerotic macrovascular events	major diseases	major inflammatory diseases	major medical illnesses	many connective tissue diseases	many consequences	many immune-related diseases	mental states	microtubule-targeted drugs	migraine trigger	multi-factorial disorder	multiple significant adverse reactions	negative factors	non-smokers.18 Other lifestyle factors	nonemotional characteristics	normal disease tissues	normal physiologic processes	organ toxicities	osteolytic bone conditions	others diseases	palliative care symptoms	pathologic tissue destruction	permanent serious disease	physical barriers	possessed risk factors	potent biochemical mediators	pre-existing chronic diseases	primary sites	prior non-malignant lung disease	progenitor states	proper cell lineages	relevant entity	respiratory system events	score,43 comorbidities	secondary dyslipidemias	significant inflammatory component	similar circumstances	skeletal muscle injuries	smoking hazards	soft tissue involvement	special medications	specific physical stimuli	specific post-stroke complications	strong vascular risk factors	systematic status	tissue symptoms	tongue symptoms	unrecognised.1 Characteristics	usual cardiovascular risk factors	various cancer entities	various health-related issues	various respiratory health problems	well-known adolescent public health problems	well-known pathologies	young adult mice	’ prenatal history	“ anti-resorptive ” agents
urology	different subspecialties
distress	Psychosocial problems
